The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma
Nasopharyngeal carcinoma (NPC) is a malignant epithelial tumor originating in the nasopharynx and has a high incidence in Southeast Asia and North Africa. To develop these comprehensive guidelines for the diagnosis and management of NPC, the Chinese Society of Clinical Oncology (CSCO) arranged a mul...
Saved in:
| Published in | Cancer communications (London, England) Vol. 41; no. 11; pp. 1195 - 1227 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
John Wiley & Sons, Inc
01.11.2021
John Wiley and Sons Inc Wiley |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Nasopharyngeal carcinoma (NPC) is a malignant epithelial tumor originating in the nasopharynx and has a high incidence in Southeast Asia and North Africa. To develop these comprehensive guidelines for the diagnosis and management of NPC, the Chinese Society of Clinical Oncology (CSCO) arranged a multi‐disciplinary team comprising of experts from all sub‐specialties of NPC to write, discuss, and revise the guidelines. Based on the findings of evidence‐based medicine in China and abroad, domestic experts have iteratively developed these guidelines to provide proper management of NPC. Overall, the guidelines describe the screening, clinical and pathological diagnosis, staging and risk assessment, therapies, and follow‐up of NPC, which aim to improve the management of NPC. |
|---|---|
| AbstractList | Nasopharyngeal carcinoma (NPC) is a malignant epithelial tumor originating in the nasopharynx and has a high incidence in Southeast Asia and North Africa. To develop these comprehensive guidelines for the diagnosis and management of NPC, the Chinese Society of Clinical Oncology (CSCO) arranged a multi‐disciplinary team comprising of experts from all sub‐specialties of NPC to write, discuss, and revise the guidelines. Based on the findings of evidence‐based medicine in China and abroad, domestic experts have iteratively developed these guidelines to provide proper management of NPC. Overall, the guidelines describe the screening, clinical and pathological diagnosis, staging and risk assessment, therapies, and follow‐up of NPC, which aim to improve the management of NPC. Nasopharyngeal carcinoma (NPC) is a malignant epithelial tumor originating in the nasopharynx and has a high incidence in Southeast Asia and North Africa. To develop these comprehensive guidelines for the diagnosis and management of NPC, the Chinese Society of Clinical Oncology (CSCO) arranged a multi-disciplinary team comprising of experts from all sub-specialties of NPC to write, discuss, and revise the guidelines. Based on the findings of evidence-based medicine in China and abroad, domestic experts have iteratively developed these guidelines to provide proper management of NPC. Overall, the guidelines describe the screening, clinical and pathological diagnosis, staging and risk assessment, therapies, and follow-up of NPC, which aim to improve the management of NPC.Nasopharyngeal carcinoma (NPC) is a malignant epithelial tumor originating in the nasopharynx and has a high incidence in Southeast Asia and North Africa. To develop these comprehensive guidelines for the diagnosis and management of NPC, the Chinese Society of Clinical Oncology (CSCO) arranged a multi-disciplinary team comprising of experts from all sub-specialties of NPC to write, discuss, and revise the guidelines. Based on the findings of evidence-based medicine in China and abroad, domestic experts have iteratively developed these guidelines to provide proper management of NPC. Overall, the guidelines describe the screening, clinical and pathological diagnosis, staging and risk assessment, therapies, and follow-up of NPC, which aim to improve the management of NPC. Abstract Nasopharyngeal carcinoma (NPC) is a malignant epithelial tumor originating in the nasopharynx and has a high incidence in Southeast Asia and North Africa. To develop these comprehensive guidelines for the diagnosis and management of NPC, the Chinese Society of Clinical Oncology (CSCO) arranged a multi‐disciplinary team comprising of experts from all sub‐specialties of NPC to write, discuss, and revise the guidelines. Based on the findings of evidence‐based medicine in China and abroad, domestic experts have iteratively developed these guidelines to provide proper management of NPC. Overall, the guidelines describe the screening, clinical and pathological diagnosis, staging and risk assessment, therapies, and follow‐up of NPC, which aim to improve the management of NPC. |
| Author | Sun, Ying Yi, Jun‐Lin Zhu, Xiao‐Dong Tang, Ling‐Long Liu, Xu Mai, Hai‐Qiang Jiang, Wei Wang, Xiao‐Shen Xia, Yun‐Fei Ma, Lin Wang, Ying Hu, Guang‐Yuan Wu, Hui Wang, Ren‐Sheng Jiang, Hao Liu, Qiu‐Fang Chen, Xiao‐Zhong Shen, Liang‐Fang Feng, Mei Lang, Jin‐Yi Han, Fei Fang, Wen‐Feng Chen, Yu‐Pei Chen, Ming‐Yuan Xiao, Shao‐Wen He, Xia Li, Jin‐Gao Hu, De‐sheng Lin, Shao‐Jun Yang, Kun‐Yu Jin, Feng Du, Xiao‐Jing Gao, Jin Wang, Pei‐Guo Chen, Chuan‐Ben Hu, Chao‐Su Chen, Nian‐Yong Qin, Ji‐Yong Wang, Ruo‐Zheng Ma, Jun |
| AuthorAffiliation | 20 Department of Radiation Oncology Yunnan Cancer Hospital The Third Affiliated Hospital of Kunming Medical University Kunming Yunnan 650100 P. R. China 12 Department of Oncology Tongji Hospital Tongji Medical College of Huazhong University of Science and Technology Wuhan Hubei 430030 P. R. China 10 Department of Radiation Oncology Fudan University Shanghai Cancer Center Shanghai 200032 P. R. China 8 Department of Radiation Oncology Anhui Provincial Hospital Affiliated to Anhui Medical University Hefei Anhui 230001 P. R. China 22 Department of Radiotherapy National Clinical Research Center for Cancer Tianjin Medical University Cancer Institute and Hospital Tianjin 300060 P. R. China 9 Department of Clinical Laboratory Affiliated Cancer Hospital of Nanjing Medical University Jiangsu Cancer Hospital Jiangsu Institute of Cancer Research Nanjing Jiangsu 210000 P. R. China 26 Department of Radiation Oncology Affiliated Cancer Hospital of Zhengzhou University Zhengzhou Henan 450000 P. R. China 24 D |
| AuthorAffiliation_xml | – name: 25 Department of Radiation Oncology Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital Chongqing 400000 P. R. China – name: 15 Key Laboratory of Basic Pharmacology and Joint International Research Laboratory of Ethnomedicine of Ministry of Education Zunyi Medical University No. 6, Xuefu West Road, Xinpu New District Zunyi Guizhou 563000 P. R. China – name: 26 Department of Radiation Oncology Affiliated Cancer Hospital of Zhengzhou University Zhengzhou Henan 450000 P. R. China – name: 23 Department of Radiation Oncology The First Affiliated Hospital of Guangxi Medical University Nanning Guangxi 530000 P. R. China – name: 10 Department of Radiation Oncology Fudan University Shanghai Cancer Center Shanghai 200032 P. R. China – name: 13 Department of Radiation Oncology The First Affiliated Hospital of Bengbu Medical College Bengbu Anhui 233004 P. R. China – name: 6 State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Medical Oncology Department Sun Yat‐Sen University Cancer Center Guangzhou Guangdong 510060 P. R. China – name: 27 Department of Radiotherapy Peking University School of Oncology Beijing Cancer Hospital and Institute Beijing Haidian District 100142 P. R. China – name: 7 Department of Radiation Oncology Sichuan Cancer Hospital and Institute Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China Chengdu Sichuan 610041 P. R. China – name: 19 Department of Radiation Oncology First Medical Center of Chinese PLA General Hospital Beijing 100000 P. R. China – name: 28 Cancer Center Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan Hubei 430022 P. R. China – name: 16 Department of Radiation Oncology Radiation Oncology Key Laboratory of Sichuan Province Sichuan Cancer Hospital & Institute School of Medicine University of Electronic Science and Technology of China Chengdu Sichuan 610041 P. R. China – name: 9 Department of Clinical Laboratory Affiliated Cancer Hospital of Nanjing Medical University Jiangsu Cancer Hospital Jiangsu Institute of Cancer Research Nanjing Jiangsu 210000 P. R. China – name: 1 Department of Radiation Oncology State Key Laboratory of Oncology in South China Collaborative Innovation Center of Cancer Medicine Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Sun Yat‐sen University Cancer Center 651 Dongfeng Road East Guangzhou Guangdong 510060 P. R. China – name: 17 Department of Radiotherapy Jiangxi Cancer Hospital Nanchang Jiangxi 330029 P. R. China – name: 8 Department of Radiation Oncology Anhui Provincial Hospital Affiliated to Anhui Medical University Hefei Anhui 230001 P. R. China – name: 22 Department of Radiotherapy National Clinical Research Center for Cancer Tianjin Medical University Cancer Institute and Hospital Tianjin 300060 P. R. China – name: 18 Department of Radiotherapy Shaanxi Provincial Cancer Hospital Affiliated to Medical College Xi'an Jiaotong University Xi'an Shaanxi 710000 P. R. China – name: 4 Department of Radiation Oncology Cancer Center, West China Hospital Sichuan University Chengdu Sichuan 610041 P. R. China – name: 14 Department of Radiation Oncology Affiliated Hospital of Guilin Medical University Guilin Guangxi 541001 P. R. China – name: 3 Department of Nasopharyngeal Carcinoma State Key Laboratory of Oncology in South China Collaborative Innovation Centre for Cancer Medicine Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Sun Yat‐sen University Cancer Center Guangzhou Guangdong 510060 P. R. China – name: 12 Department of Oncology Tongji Hospital Tongji Medical College of Huazhong University of Science and Technology Wuhan Hubei 430030 P. R. China – name: 20 Department of Radiation Oncology Yunnan Cancer Hospital The Third Affiliated Hospital of Kunming Medical University Kunming Yunnan 650100 P. R. China – name: 24 Department of Radiation Oncology Key Laboratory of Oncology in Xinjiang Uyghur Autonomous Region The Affiliated Tumor Hospital of Xinjiang Medical University Urumqi Xinjiang 830000 P. R. China – name: 21 Department of Radiation Oncology Xiangya Hospital of Central South University 87 Xiangya Road Changsha Hunan 410008 P. R. China – name: 30 Department of Radiotherapy Guangxi Medical University Cancer Hospital Nanning Guangxi 530000 P. R. China – name: 5 Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital) Institute of Cancer and Basic Medicine (IBMC) Chinese Academy of Sciences Hangzhou Zhejiang 310000 P. R. China – name: 11 Department of Radiotherapy Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan Hubei 430079 P. R. China – name: 29 Department of Radiation Oncology National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100021 P. R. China – name: 2 Department of Radiation Oncology Fujian Provincial Cancer Hospital Fujian Medical University Department of Radiation Oncology Teaching Hospital of Fujian Medical University Provincial Clinical College Cancer Hospital of Fujian Medical University Fuzhou Fujian 350014 P. R. China |
| Author_xml | – sequence: 1 givenname: Ling‐Long orcidid: 0000-0002-8561-1454 surname: Tang fullname: Tang, Ling‐Long organization: Sun Yat‐sen University Cancer Center – sequence: 2 givenname: Yu‐Pei surname: Chen fullname: Chen, Yu‐Pei organization: Sun Yat‐sen University Cancer Center – sequence: 3 givenname: Chuan‐Ben surname: Chen fullname: Chen, Chuan‐Ben organization: Cancer Hospital of Fujian Medical University – sequence: 4 givenname: Ming‐Yuan orcidid: 0000-0003-4793-0902 surname: Chen fullname: Chen, Ming‐Yuan organization: Sun Yat‐sen University Cancer Center – sequence: 5 givenname: Nian‐Yong surname: Chen fullname: Chen, Nian‐Yong organization: Sichuan University – sequence: 6 givenname: Xiao‐Zhong surname: Chen fullname: Chen, Xiao‐Zhong organization: Chinese Academy of Sciences – sequence: 7 givenname: Xiao‐Jing surname: Du fullname: Du, Xiao‐Jing organization: Sun Yat‐sen University Cancer Center – sequence: 8 givenname: Wen‐Feng surname: Fang fullname: Fang, Wen‐Feng organization: Sun Yat‐Sen University Cancer Center – sequence: 9 givenname: Mei surname: Feng fullname: Feng, Mei organization: Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China – sequence: 10 givenname: Jin surname: Gao fullname: Gao, Jin organization: Anhui Provincial Hospital Affiliated to Anhui Medical University – sequence: 11 givenname: Fei orcidid: 0000-0002-1598-9048 surname: Han fullname: Han, Fei organization: Sun Yat‐sen University Cancer Center – sequence: 12 givenname: Xia surname: He fullname: He, Xia organization: Jiangsu Institute of Cancer Research – sequence: 13 givenname: Chao‐Su surname: Hu fullname: Hu, Chao‐Su organization: Fudan University Shanghai Cancer Center – sequence: 14 givenname: De‐sheng surname: Hu fullname: Hu, De‐sheng organization: Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology – sequence: 15 givenname: Guang‐Yuan surname: Hu fullname: Hu, Guang‐Yuan organization: Tongji Medical College of Huazhong University of Science and Technology – sequence: 16 givenname: Hao surname: Jiang fullname: Jiang, Hao organization: The First Affiliated Hospital of Bengbu Medical College – sequence: 17 givenname: Wei surname: Jiang fullname: Jiang, Wei organization: Affiliated Hospital of Guilin Medical University – sequence: 18 givenname: Feng surname: Jin fullname: Jin, Feng organization: Zunyi Medical University – sequence: 19 givenname: Jin‐Yi surname: Lang fullname: Lang, Jin‐Yi organization: University of Electronic Science and Technology of China – sequence: 20 givenname: Jin‐Gao surname: Li fullname: Li, Jin‐Gao organization: Jiangxi Cancer Hospital – sequence: 21 givenname: Shao‐Jun orcidid: 0000-0001-7164-9761 surname: Lin fullname: Lin, Shao‐Jun organization: Cancer Hospital of Fujian Medical University – sequence: 22 givenname: Xu surname: Liu fullname: Liu, Xu organization: Sun Yat‐sen University Cancer Center – sequence: 23 givenname: Qiu‐Fang surname: Liu fullname: Liu, Qiu‐Fang organization: Xi'an Jiaotong University – sequence: 24 givenname: Lin surname: Ma fullname: Ma, Lin organization: First Medical Center of Chinese PLA General Hospital – sequence: 25 givenname: Hai‐Qiang orcidid: 0000-0003-0214-203X surname: Mai fullname: Mai, Hai‐Qiang organization: Sun Yat‐sen University Cancer Center – sequence: 26 givenname: Ji‐Yong surname: Qin fullname: Qin, Ji‐Yong organization: The Third Affiliated Hospital of Kunming Medical University – sequence: 27 givenname: Liang‐Fang surname: Shen fullname: Shen, Liang‐Fang organization: Xiangya Hospital of Central South University – sequence: 28 givenname: Ying orcidid: 0000-0002-5888-2929 surname: Sun fullname: Sun, Ying organization: Sun Yat‐sen University Cancer Center – sequence: 29 givenname: Pei‐Guo surname: Wang fullname: Wang, Pei‐Guo organization: Tianjin Medical University Cancer Institute and Hospital – sequence: 30 givenname: Ren‐Sheng surname: Wang fullname: Wang, Ren‐Sheng organization: The First Affiliated Hospital of Guangxi Medical University – sequence: 31 givenname: Ruo‐Zheng surname: Wang fullname: Wang, Ruo‐Zheng organization: The Affiliated Tumor Hospital of Xinjiang Medical University – sequence: 32 givenname: Xiao‐Shen surname: Wang fullname: Wang, Xiao‐Shen organization: Fudan University Shanghai Cancer Center – sequence: 33 givenname: Ying surname: Wang fullname: Wang, Ying organization: Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital – sequence: 34 givenname: Hui surname: Wu fullname: Wu, Hui organization: Affiliated Cancer Hospital of Zhengzhou University – sequence: 35 givenname: Yun‐Fei surname: Xia fullname: Xia, Yun‐Fei organization: Sun Yat‐sen University Cancer Center – sequence: 36 givenname: Shao‐Wen surname: Xiao fullname: Xiao, Shao‐Wen organization: Beijing Cancer Hospital and Institute – sequence: 37 givenname: Kun‐Yu surname: Yang fullname: Yang, Kun‐Yu organization: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology – sequence: 38 givenname: Jun‐Lin orcidid: 0000-0002-7083-0216 surname: Yi fullname: Yi, Jun‐Lin organization: Chinese Academy of Medical Sciences and Peking Union Medical College – sequence: 39 givenname: Xiao‐Dong surname: Zhu fullname: Zhu, Xiao‐Dong organization: Guangxi Medical University Cancer Hospital – sequence: 40 givenname: Jun orcidid: 0000-0002-1137-9349 surname: Ma fullname: Ma, Jun email: majun2@mail.sysu.edu.cn organization: Sun Yat‐sen University Cancer Center |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34699681$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kk9rHCEYxqWkNOk2l36AIvSSFDb1z4yjl0AY0jYQ2EPSszjqzLq4utXZlj31q9fJZksSSk_q6_P8fNT3LTgKMVgA3mN0gREin7XS5AITgvkrcEJqQue0rvjRk_kxOM15hRDCgouqpm_AMa2YEIzjE_D7fmlhu3TBZgvvonZ23MHYw9a74LTycBF09HHYwbP2rl2cQ33YGLbOWD8ZYR8THAvHODWEmF2GKhg4JqvGtQ3jxAsqx81SpV0YbDFrlbQLca3egde98tmePo4z8P3L9X37bX67-HrTXt3ONasaPqdGG1UrwSttWUdRJ4zgVjS446bmrCdVxZnQvcGs1JnpekUt7xpMCemI6OkM3Oy5JqqV3CS3LllkVE4-FGIapEqj095Kgztq-qYyhvKqtlY1pCwxJ0p1vCmnz8DlnrXZdmtrdLliUv4Z9PlOcEs5xJ-SM8IYIgVw9ghI8cfW5lGuXdbWexVs3GZJat4gVHGBivTjC-kqblMoTyVJQfGGIDwBPzxN9DfK4Z-LAO0FOsWck-2ldqMaXZwCOi8xklM3yamb5EM3FcunF5YD9Z9ivBf_ct7u_qOU7VVL9p4_jw_ahA |
| CitedBy_id | crossref_primary_10_3389_fpubh_2024_1526147 crossref_primary_10_1136_bmjopen_2023_071832 crossref_primary_10_12677_acm_2024_1451500 crossref_primary_10_3390_curroncol30010017 crossref_primary_10_1007_s10495_023_01884_8 crossref_primary_10_1002_jmri_28842 crossref_primary_10_3233_THC_231173 crossref_primary_10_1016_j_oraloncology_2024_106891 crossref_primary_10_3390_biom14091142 crossref_primary_10_1007_s11654_024_00560_w crossref_primary_10_1016_j_semradonc_2025_01_003 crossref_primary_10_1038_s41467_023_36523_y crossref_primary_10_61186_ijrr_22_3_803 crossref_primary_10_4103_jcrt_jcrt_318_22 crossref_primary_10_1111_coa_14299 crossref_primary_10_1016_j_ejrad_2023_111084 crossref_primary_10_1186_s12860_023_00477_2 crossref_primary_10_1016_j_isci_2024_110431 crossref_primary_10_1007_s00405_024_08500_8 crossref_primary_10_1186_s40644_025_00827_7 crossref_primary_10_1007_s00405_024_08714_w crossref_primary_10_1002_hed_27172 crossref_primary_10_1016_j_anl_2022_09_010 crossref_primary_10_20960_revcancer_00076 crossref_primary_10_1002_cam4_6816 crossref_primary_10_1016_j_prp_2024_155460 crossref_primary_10_1016_j_radonc_2022_109447 crossref_primary_10_1016_j_radonc_2023_109743 crossref_primary_10_1007_s00259_022_06020_3 crossref_primary_10_1016_j_oraloncology_2024_106980 crossref_primary_10_1007_s00330_022_09232_1 crossref_primary_10_1016_j_canrad_2023_07_006 crossref_primary_10_1016_S0167_8140_24_00459_6 crossref_primary_10_1177_15347354251314499 crossref_primary_10_3390_jcm13164821 crossref_primary_10_1016_j_mri_2023_10_006 crossref_primary_10_1007_s00262_024_03698_2 crossref_primary_10_1007_s44178_023_00040_1 crossref_primary_10_1177_17588359241233235 crossref_primary_10_2147_JIR_S411194 crossref_primary_10_1136_jitc_2024_010091 crossref_primary_10_1158_1078_0432_CCR_23_3608 crossref_primary_10_1002_cac2_12347 crossref_primary_10_25259_Cytojournal_149_2024 crossref_primary_10_1016_j_brainresbull_2024_111106 crossref_primary_10_3389_fonc_2023_1114652 crossref_primary_10_3233_XST_230024 crossref_primary_10_1038_s41746_024_01403_2 crossref_primary_10_1186_s13027_024_00631_1 crossref_primary_10_1136_bmjopen_2024_091087 crossref_primary_10_2139_ssrn_4156709 crossref_primary_10_3389_fonc_2022_927510 crossref_primary_10_7717_peerj_18773 crossref_primary_10_1038_s41419_023_06225_w crossref_primary_10_1080_14796694_2024_2386926 crossref_primary_10_1002_hed_27448 crossref_primary_10_1016_j_radonc_2024_110497 crossref_primary_10_3389_fonc_2022_1010131 crossref_primary_10_1038_s41467_024_49675_2 crossref_primary_10_1016_j_oraloncology_2024_106725 crossref_primary_10_1177_11795549231225419 crossref_primary_10_5306_wjco_v16_i2_95642 crossref_primary_10_3892_ol_2022_13584 crossref_primary_10_1016_j_compbiomed_2024_108120 crossref_primary_10_1038_s41598_024_58233_1 crossref_primary_10_3390_microorganisms11030719 crossref_primary_10_1097_MD_0000000000038416 crossref_primary_10_3892_ol_2023_13790 crossref_primary_10_1177_10732748241251562 crossref_primary_10_1186_s12885_024_12259_w crossref_primary_10_1002_advs_202205668 crossref_primary_10_1016_j_phymed_2025_156484 crossref_primary_10_1016_j_ccell_2025_01_014 crossref_primary_10_1038_s41416_024_02579_w crossref_primary_10_1186_s13014_022_02017_2 crossref_primary_10_1186_s40001_024_02137_3 crossref_primary_10_1002_lio2_1161 crossref_primary_10_1016_j_xcrm_2024_101753 crossref_primary_10_2147_CMAR_S460716 crossref_primary_10_1016_j_ejmech_2023_115207 crossref_primary_10_1016_j_ijbiomac_2024_134837 crossref_primary_10_1021_acsnano_4c07676 crossref_primary_10_3390_jcm12093077 crossref_primary_10_1016_j_phymed_2024_156085 crossref_primary_10_3892_ol_2025_14871 crossref_primary_10_1002_hed_27424 crossref_primary_10_1002_hed_27665 crossref_primary_10_1016_j_apjon_2023_100251 crossref_primary_10_1016_j_oraloncology_2024_106828 crossref_primary_10_1186_s41021_024_00304_w crossref_primary_10_2147_TCRM_S489899 crossref_primary_10_1002_1878_0261_13375 crossref_primary_10_3390_cancers15061689 crossref_primary_10_1038_s41467_023_40402_x crossref_primary_10_1186_s13014_022_02104_4 crossref_primary_10_1007_s11604_024_01587_3 crossref_primary_10_1016_j_ctro_2024_100861 crossref_primary_10_1016_j_ejrad_2024_111752 crossref_primary_10_1002_ijc_35340 crossref_primary_10_1186_s12967_023_04654_x crossref_primary_10_1155_2022_1787854 crossref_primary_10_3389_fmed_2022_996127 crossref_primary_10_2147_DDDT_S399937 crossref_primary_10_1056_NEJMoa2301496 crossref_primary_10_1186_s12885_022_10297_w crossref_primary_10_1016_j_oraloncology_2022_105842 crossref_primary_10_1007_s13258_023_01380_y crossref_primary_10_1007_s00520_024_08646_5 crossref_primary_10_1016_j_isci_2023_108347 crossref_primary_10_1002_alr_23161 crossref_primary_10_1002_hed_27360 crossref_primary_10_1186_s12916_025_03964_9 crossref_primary_10_3892_ol_2024_14385 crossref_primary_10_1007_s00259_024_06744_4 crossref_primary_10_1097_MD_0000000000036477 crossref_primary_10_3389_fpubh_2022_1086393 crossref_primary_10_3389_fcell_2023_1100941 crossref_primary_10_3389_fonc_2024_1383250 crossref_primary_10_1038_s41698_024_00601_1 crossref_primary_10_1166_jbn_2024_3809 crossref_primary_10_3389_fsurg_2022_1099416 crossref_primary_10_1158_1055_9965_EPI_23_1486 crossref_primary_10_1002_hed_27452 crossref_primary_10_1007_s13402_024_01016_7 crossref_primary_10_1002_cam4_6764 crossref_primary_10_1016_j_heliyon_2024_e31557 crossref_primary_10_1007_s00405_022_07794_w crossref_primary_10_1007_s00520_025_09273_4 crossref_primary_10_1186_s12885_024_12499_w crossref_primary_10_20517_2574_1225_2023_124 crossref_primary_10_3389_fonc_2024_1460426 crossref_primary_10_1016_j_heliyon_2024_e37897 crossref_primary_10_1038_s41598_024_81350_w crossref_primary_10_1016_j_radonc_2023_109904 crossref_primary_10_1177_2050313X241281323 crossref_primary_10_1016_j_radmp_2023_10_001 crossref_primary_10_1177_03936155241249186 crossref_primary_10_1080_07853890_2024_2383959 crossref_primary_10_1002_cbf_3939 crossref_primary_10_1186_s12885_023_11608_5 crossref_primary_10_1002_hed_27581 crossref_primary_10_1016_j_lfs_2024_122856 crossref_primary_10_3389_fpubh_2022_912843 crossref_primary_10_1038_s41419_024_06496_x crossref_primary_10_3390_ijerph20042926 crossref_primary_10_1126_sciadv_add0960 crossref_primary_10_62347_RIWX7204 crossref_primary_10_1016_j_radonc_2023_109716 crossref_primary_10_1002_hed_27277 crossref_primary_10_1002_cam4_7359 crossref_primary_10_1186_s13046_024_02945_9 crossref_primary_10_1186_s12935_022_02776_8 crossref_primary_10_3389_fonc_2023_1192953 crossref_primary_10_1097_MNM_0000000000001682 crossref_primary_10_3389_fonc_2022_807052 crossref_primary_10_3389_fimmu_2024_1415246 crossref_primary_10_3389_fnut_2023_1162280 crossref_primary_10_1007_s00432_023_05041_1 crossref_primary_10_3389_fnut_2024_1413117 crossref_primary_10_1016_j_clinsp_2025_100577 crossref_primary_10_1016_j_imbio_2022_152314 crossref_primary_10_1016_j_radonc_2025_110713 crossref_primary_10_1016_j_radonc_2023_109721 crossref_primary_10_1021_acsomega_4c06191 crossref_primary_10_37990_medr_1305549 crossref_primary_10_1007_s00405_023_08157_9 crossref_primary_10_1097_CM9_0000000000003371 crossref_primary_10_3389_fphar_2024_1366853 crossref_primary_10_1007_s12149_024_01949_x crossref_primary_10_1186_s12885_022_09626_w crossref_primary_10_1016_j_acra_2025_02_034 crossref_primary_10_1007_s00432_023_04952_3 crossref_primary_10_1002_cam4_6723 crossref_primary_10_1177_17588359241286222 crossref_primary_10_1016_j_esmoop_2023_101629 crossref_primary_10_1371_journal_pone_0287031 crossref_primary_10_1016_j_bjorl_2023_101358 crossref_primary_10_12677_ACM_2023_132262 crossref_primary_10_12677_ACM_2023_131051 crossref_primary_10_3389_fonc_2024_1377366 crossref_primary_10_1155_2022_5655009 crossref_primary_10_3390_cancers16183237 crossref_primary_10_12998_wjcc_v12_i24_5628 crossref_primary_10_1016_j_eclinm_2022_101625 crossref_primary_10_1016_j_xcrm_2024_101594 crossref_primary_10_3389_fonc_2025_1506778 crossref_primary_10_3390_healthcare12141452 crossref_primary_10_2174_0118715206319761240705115109 crossref_primary_10_1002_cam4_6614 crossref_primary_10_1155_2022_5145549 crossref_primary_10_1177_17588359231177016 crossref_primary_10_1002_advs_202403262 crossref_primary_10_1021_acs_molpharmaceut_3c01172 crossref_primary_10_3390_cancers16050918 crossref_primary_10_4103_jmp_jmp_223_24 crossref_primary_10_3389_fonc_2023_1228994 crossref_primary_10_1177_15353702231167940 crossref_primary_10_1002_cam4_70389 crossref_primary_10_1007_s00330_023_09742_6 crossref_primary_10_1080_09553002_2025_2470226 crossref_primary_10_1016_j_jvoice_2024_04_017 crossref_primary_10_1186_s12962_024_00515_6 crossref_primary_10_1007_s00234_022_02941_w |
| Cites_doi | 10.1016/S0140-6736(21)01123-5 10.1007/s00280-007-0641-2 10.1634/theoncologist.2016-0105 10.1200/JCO.2017.35.15_suppl.6006 10.1002/cncr.31741 10.1186/s40880-016-0167-2 10.1016/j.ijrobp.2009.03.059 10.1080/00016480701813806 10.1016/S1368-8375(02)00120-3 10.1016/j.ijrobp.2019.02.040 10.1097/00005537-200210000-00033 10.1259/bjr/42085182 10.1002/hed.23633 10.1016/j.ijrobp.2018.01.117 10.1002/mp.12810 10.3727/096504014X13983417587401 10.1016/j.ijrobp.2007.10.067 10.3389/fonc.2020.00119 10.1056/NEJMoa1701717 10.1200/JCO.2004.00.3863 10.1002/hed.23719 10.3322/caac.21338 10.1118/1.1843354 10.1016/j.ijrobp.2018.04.069 10.1002/cncr.24049 10.1007/s10147-013-0650-6 10.1016/S0360-3016(00)00585-X 10.1200/JCO.2016.67.4119 10.1023/A:1008390929826 10.1200/JCO.20.02712 10.1016/j.ijrobp.2004.09.057 10.1016/j.ijrobp.2008.12.033 10.1016/j.ejca.2016.12.039 10.1088/0031-9155/51/19/008 10.1016/j.ijrobp.2008.11.053 10.1016/j.ijrobp.2011.10.073 10.1038/bjc.2017.357 10.1002/cncr.30850 10.1007/s00432-012-1219-x 10.1016/j.radonc.2013.10.020 10.1016/j.ijrobp.2011.07.006 10.1016/j.oraloncology.2017.03.015 10.1038/s41467-020-17672-w 10.1200/JCO.2002.08.149 10.1200/JCO.2005.16.790 10.1016/j.ijrobp.2007.12.028 10.1093/annonc/mdz231 10.1016/j.ejca.2015.05.025 10.18632/oncotarget.13564 10.1259/bjr/17748030 10.1088/0031-9155/52/13/002 10.1016/j.ejca.2012.06.009 10.1016/j.radonc.2012.08.013 10.1002/cncr.20129 10.1016/j.radonc.2015.11.030 10.1002/mp.13663 10.1016/j.radonc.2017.10.032 10.1016/j.radonc.2018.09.004 10.1016/j.radonc.2015.04.024 10.1016/j.radonc.2020.06.049 10.1002/hed.23977 10.1016/j.phro.2020.06.006 10.1093/annonc/mdq425 10.3389/fonc.2020.00930 10.1200/JCO.2017.73.3675 10.1200/JCO.2012.46.0816 10.2147/CMAR.S197544 10.1186/s12885-016-2517-5 10.1002/cncr.28201 10.1186/s40880-016-0103-5 10.1200/JCO.2005.12.081 10.1002/hed.20310 10.1016/S0140-6736(15)00055-0 10.1016/0360-3016(94)00412-E 10.1002/ijc.32099 10.1016/j.ijrobp.2011.08.001 10.1016/j.ijrobp.2009.06.062 10.1017/S0022215116000451 10.1016/j.annonc.2020.12.007 10.1120/jacmp.v17i3.6088 10.1200/JCO.2008.19.9109 10.1002/mp.13927 10.1038/bjc.2013.715 10.1148/radiol.2491071753 10.7150/thno.19710 10.1016/j.oraloncology.2019.04.022 10.1007/s00259-018-3986-3 10.1016/j.ejca.2015.04.027 10.1016/j.ijrobp.2015.09.035 10.1016/S1470-2045(15)70126-9 10.3322/caac.21492 10.1371/journal.pone.0194733 10.1016/j.radonc.2017.07.020 10.1016/j.radonc.2009.09.013 10.1016/j.ijrobp.2017.11.004 10.1186/s13014-018-1087-x 10.1016/j.oraloncology.2013.05.005 10.7150/jca.17957 10.1148/radiol.2019182012 10.1093/annonc/mdt163 10.3322/caac.21262 10.1016/S1470-2045(21)00302-8 10.1002/jmrs.189 10.1093/annonc/mdx770 10.1186/1748-717X-9-87 10.1016/j.ijrobp.2011.09.054 10.3389/fonc.2020.01314 10.1002/cncr.26069 10.1093/jnci/djq258 10.1038/s41591-021-01444-0 10.1007/s00280-007-0441-8 10.1093/jnci/djx007 10.1002/hed.20161 10.1016/j.tipsro.2016.12.001 10.1016/j.radonc.2011.11.017 10.7150/jca.21582 10.1093/oxfordjournals.annonc.a058703 10.1016/j.annonc.2020.10.264 10.21037/atm.2018.05.14 10.1007/s00280-012-2020-x 10.1016/j.ejca.2015.08.006 10.1002/ijc.1004 10.1016/S0140-6736(16)31388-5 10.1200/JCO.20.03237 10.1200/JCO.2008.18.1545 10.1200/JCO.1998.16.4.1310 10.4143/crt.2018.298 10.1097/MD.0000000000015951 10.1016/j.oraloncology.2012.05.021 10.1016/j.ejca.2018.10.020 10.1056/NEJMoa1905287 10.1200/JCO.2007.11.5501 10.1016/j.ejca.2007.03.022 10.1016/j.ijrobp.2004.07.696 10.1002/cncr.29208 10.1002/hed.20974 10.1016/j.canlet.2016.01.040 10.1016/j.oraloncology.2017.03.010 10.1002/cncr.11519 10.1186/s13014-015-0401-0 10.1016/j.radonc.2010.04.014 10.1016/j.ejca.2010.10.026 10.1016/j.ijrobp.2019.03.043 10.1016/j.ijrobp.2008.03.017 10.7150/thno.21815 10.1007/s002800050512 10.1001/jamaoncol.2020.1808 10.1111/cas.13589 10.1016/j.ejca.2017.01.002 10.1002/cncr.32972 10.1016/j.oraloncology.2013.02.006 10.1016/S1470-2045(16)30410-7 10.1016/j.ijrobp.2006.06.013 10.1016/S1470-2045(20)30673-2 10.1016/j.radonc.2019.09.022 10.1016/j.ijrobp.2019.06.2549 10.1158/1078-0432.CCR-17-2656 10.1118/1.4876299 10.1186/s12885-015-1669-z 10.1093/annonc/mdu507 10.1016/j.currproblcancer.2020.100620 10.1002/mp.14075 10.1002/cncr.32770 10.1016/S0140-6736(19)30956-0 10.1016/j.ijrobp.2006.03.054 10.1186/s13014-019-1387-9 10.1200/JCO.2017.75.5165 10.1007/978-3-319-40618-3 10.1371/journal.pone.0219611 10.1118/1.3514120 10.1016/S0167-8140(00)00192-4 10.1016/j.radonc.2013.10.035 10.1093/jnci/djr432 10.1186/s40880-017-0256-x 10.1016/j.ejca.2019.07.007 10.1200/JCO.2017.77.0388 10.1002/cncr.20802 10.1097/RMR.0b013e3181572b3a 10.1186/s40880-017-0265-9 10.1093/jnci/dji084 10.1016/S1470-2045(18)30495-9 10.1002/lary.27317 10.1016/j.ijrobp.2019.06.2540 10.1016/j.ejca.2015.05.014 10.1016/j.ijrobp.2010.07.017 10.1016/j.radonc.2015.05.012 10.1016/j.oraloncology.2016.11.008 10.1586/era.10.9 10.1016/j.oraloncology.2018.04.025 10.1016/j.ctrv.2019.101890 10.1002/ijc.30819 10.1002/hed.23314 10.1002/hed.21928 |
| ContentType | Journal Article |
| Copyright | 2021 The Authors. published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat‐sen University Cancer Center 2021 The Authors. Cancer Communications published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat-sen University Cancer Center. 2021. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: 2021 The Authors. published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat‐sen University Cancer Center – notice: 2021 The Authors. Cancer Communications published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat-sen University Cancer Center. – notice: 2021. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9- K9. KB0 M0R M0S M1P NAPCQ PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM DOA |
| DOI | 10.1002/cac2.12218 |
| DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Consumer Health Database Health & Medical Collection (Alumni) Medical Database (ProQuest) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Family Health (Alumni Edition) ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | CrossRef MEDLINE - Academic MEDLINE Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| DocumentTitleAlternate | TANG et al |
| EISSN | 2523-3548 |
| EndPage | 1227 |
| ExternalDocumentID | oai_doaj_org_article_d1b3df74dd3845eea72df7182aab876b PMC8626602 34699681 10_1002_cac2_12218 CAC212218 |
| Genre | article Journal Article |
| GeographicLocations | China |
| GeographicLocations_xml | – name: China |
| GroupedDBID | 0R~ 1OC 24P 7RV 7X7 88E 8FI 8FJ ABUWG ACCMX ACRMQ ACXQS ADKYN ADPDF ADUKV ADZMN ADZOD AFKRA AHSBF ALMA_UNASSIGNED_HOLDINGS ALUQN AMKLP AVUZU AZQEC BENPR BMC C24 C6C CCPQU EBS EJD FYUFA GROUPED_DOAJ HMCUK HYE IAO IHR IHW ITC K9- M0R M1P M~E NAPCQ OK1 OVD OVEED PIMPY PSQYO ROL RPM RSV SOJ TEORI UKHRP WIN AAYXX CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK DWQXO K9. PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM PUEGO |
| ID | FETCH-LOGICAL-c6478-3dcda5a984ce6b30b9d98e971b8d586f244869cfd1698e6dbfa3e8b71322b29f3 |
| IEDL.DBID | 24P |
| ISSN | 2523-3548 |
| IngestDate | Wed Aug 27 01:16:27 EDT 2025 Thu Aug 21 17:59:56 EDT 2025 Fri Jul 11 09:18:59 EDT 2025 Fri Jul 25 08:02:22 EDT 2025 Thu Apr 03 07:03:10 EDT 2025 Thu Apr 24 23:00:10 EDT 2025 Tue Jul 01 02:29:16 EDT 2025 Wed Jan 22 16:28:16 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 11 |
| Keywords | Nasopharyngeal carcinoma Chemotherapy CSCO Chinese Society of Clinical Oncology Staging Immunotherapy Surgery Risk Diagnosis Radiotherapy |
| Language | English |
| License | Attribution-NonCommercial-NoDerivs 2021 The Authors. Cancer Communications published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat-sen University Cancer Center. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c6478-3dcda5a984ce6b30b9d98e971b8d586f244869cfd1698e6dbfa3e8b71322b29f3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0003-4793-0902 0000-0001-7164-9761 0000-0003-0214-203X 0000-0002-1137-9349 0000-0002-5888-2929 0000-0002-8561-1454 0000-0002-7083-0216 0000-0002-1598-9048 |
| OpenAccessLink | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcac2.12218 |
| PMID | 34699681 |
| PQID | 2602872012 |
| PQPubID | 2040150 |
| PageCount | 33 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_d1b3df74dd3845eea72df7182aab876b pubmedcentral_primary_oai_pubmedcentral_nih_gov_8626602 proquest_miscellaneous_2587004890 proquest_journals_2602872012 pubmed_primary_34699681 crossref_citationtrail_10_1002_cac2_12218 crossref_primary_10_1002_cac2_12218 wiley_primary_10_1002_cac2_12218_CAC212218 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | November 2021 |
| PublicationDateYYYYMMDD | 2021-11-01 |
| PublicationDate_xml | – month: 11 year: 2021 text: November 2021 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: Hoboken |
| PublicationTitle | Cancer communications (London, England) |
| PublicationTitleAlternate | Cancer Commun (Lond) |
| PublicationYear | 2021 |
| Publisher | John Wiley & Sons, Inc John Wiley and Sons Inc Wiley |
| Publisher_xml | – name: John Wiley & Sons, Inc – name: John Wiley and Sons Inc – name: Wiley |
| References | 2010; 10 2019; 291 2019; 94 2011; 117 2019; 11 2019; 98 2019; 14 1995; 32 2010; 102 2005; 62 2016; 388 2016; 387 2020; 15 2013; 71 2020; 11 2020; 10 2005; 61 2018; 45 2012; 13 2016; 35 2009; 115 1998; 16 2018; 6 2017; 75 2013; 119 2021; 398 2009; 93 2005; 103 2006; 28 2006; 25 2014; 19 2019; 394 2012; 138 2018; 36 2007; 18 2016; 38 Suppl 1 2017; 64 2018; 100 2018; 29 2021; 45 2006; 51 2019; 30 2017; 69 2020; 142 2015; 51 2019; 32 2018; 102 2011; 81 2018; 101 2015; 121 2019; 104 2019; 105 2008; 249 2008; 128 2016; 94 2003; 39 2018; 109 2014; 41 2012; 104 2016; 17 2017; 377 2011; 6 2016; 16 2012; 34 2018; 24 2018; 19 2016; 7 2009; 74 2009; 75 2015; 115 2019; 46 2020; 150 2015; 65 2016; 21 2014; 36 2005; 97 2017; 141 2012; 48 2016; 8 2018; 13 2017; 7 2015; 37 2017; 8 2017; 1 2019; 51 2021; 22 2000; 48 2013; 21 2013; 24 2018; 129 2018; 126 2002; 112 2020; 126 2019; 125 2018; 82 2019; 129 2008; 72 2005; 27 2008; 70 1996; 38 2008; 71 2003; 98 2005; 23 2017; 117 2020; 6 2021; 32 2017; 36 2000; 56 2006; 66 2016; 118 2021; 39 2017; 35 2011; 22 2005; 32 2020; 47 1999; 10 2019; 119 2008; 61 2014; 9 2008; 62 2017; 123 2014; 50 1962; 81 2007; 25 2001; 96 2019; 110 2012; 83 2010; 77 2004; 100 2010; 76 2015; 15 2015; 16 2013; 49 2019; 79 2015; 10 2006 2008; 13 2007; 52 2014; 110 2011; 38 2019; 381 2009; 27 2003; 76 2019; 145 2018; 68 2015; 24 2017; 109 2011; 103 2015; 26 2009; 31 2002; 20 2021 2020 2013; 31 2019 2018 2016; 374 2017 2011; 47 2007; 43 2010; 96 1994; 5 2016; 130 2016; 66 2012; 84 e_1_2_16_23_1 e_1_2_16_46_1 e_1_2_16_69_1 Chen WS (e_1_2_16_12_1) 2016; 8 e_1_2_16_113_1 e_1_2_16_136_1 e_1_2_16_84_1 e_1_2_16_61_1 e_1_2_16_101_1 e_1_2_16_162_1 e_1_2_16_185_1 e_1_2_16_19_1 e_1_2_16_34_1 e_1_2_16_11_1 e_1_2_16_109_1 e_1_2_16_124_1 e_1_2_16_147_1 e_1_2_16_95_1 e_1_2_16_72_1 e_1_2_16_9_1 e_1_2_16_112_1 e_1_2_16_196_1 e_1_2_16_173_1 e_1_2_16_150_1 e_1_2_16_207_1 e_1_2_16_68_1 e_1_2_16_200_1 e_1_2_16_60_1 e_1_2_16_83_1 e_1_2_16_114_1 e_1_2_16_137_1 e_1_2_16_186_1 e_1_2_16_163_1 e_1_2_16_140_1 e_1_2_16_18_1 e_1_2_16_56_1 e_1_2_16_79_1 e_1_2_16_33_1 e_1_2_16_102_1 e_1_2_16_71_1 e_1_2_16_94_1 e_1_2_16_10_1 e_1_2_16_125_1 e_1_2_16_148_1 e_1_2_16_8_1 e_1_2_16_197_1 e_1_2_16_151_1 e_1_2_16_174_1 e_1_2_16_29_1 e_1_2_16_67_1 e_1_2_16_119_1 e_1_2_16_44_1 e_1_2_16_21_1 e_1_2_16_157_1 e_1_2_16_82_1 e_1_2_16_122_1 e_1_2_16_145_1 e_1_2_16_160_1 e_1_2_16_183_1 e_1_2_16_17_1 e_1_2_16_78_1 e_1_2_16_32_1 e_1_2_16_55_1 e_1_2_16_70_1 e_1_2_16_107_1 e_1_2_16_168_1 e_1_2_16_93_1 e_1_2_16_110_1 e_1_2_16_156_1 e_1_2_16_133_1 e_1_2_16_3_1 e_1_2_16_171_1 e_1_2_16_194_1 e_1_2_16_205_1 e_1_2_16_28_1 e_1_2_16_89_1 e_1_2_16_2_1 e_1_2_16_43_1 e_1_2_16_66_1 e_1_2_16_135_1 e_1_2_16_20_1 e_1_2_16_81_1 e_1_2_16_158_1 e_1_2_16_100_1 e_1_2_16_184_1 e_1_2_16_161_1 e_1_2_16_39_1 e_1_2_16_16_1 e_1_2_16_31_1 e_1_2_16_77_1 e_1_2_16_54_1 e_1_2_16_108_1 e_1_2_16_146_1 e_1_2_16_92_1 e_1_2_16_169_1 e_1_2_16_111_1 e_1_2_16_134_1 e_1_2_16_195_1 e_1_2_16_172_1 e_1_2_16_206_1 Xu S (e_1_2_16_45_1) 2015; 24 e_1_2_16_27_1 e_1_2_16_117_1 e_1_2_16_42_1 e_1_2_16_88_1 e_1_2_16_65_1 e_1_2_16_120_1 e_1_2_16_143_1 e_1_2_16_166_1 e_1_2_16_189_1 e_1_2_16_80_1 e_1_2_16_181_1 e_1_2_16_15_1 e_1_2_16_38_1 Ciuleanu E (e_1_2_16_159_1) 2008; 13 e_1_2_16_30_1 e_1_2_16_53_1 e_1_2_16_76_1 e_1_2_16_99_1 e_1_2_16_105_1 e_1_2_16_128_1 e_1_2_16_91_1 e_1_2_16_131_1 e_1_2_16_177_1 e_1_2_16_154_1 e_1_2_16_5_1 e_1_2_16_192_1 e_1_2_16_203_1 e_1_2_16_26_1 e_1_2_16_49_1 Chan ATC (e_1_2_16_123_1) 2018 e_1_2_16_41_1 e_1_2_16_64_1 e_1_2_16_87_1 e_1_2_16_118_1 e_1_2_16_179_1 e_1_2_16_121_1 e_1_2_16_167_1 e_1_2_16_144_1 e_1_2_16_182_1 e_1_2_16_14_1 e_1_2_16_37_1 e_1_2_16_98_1 e_1_2_16_52_1 e_1_2_16_129_1 e_1_2_16_75_1 Shueng PW (e_1_2_16_74_1) 2011; 6 e_1_2_16_106_1 e_1_2_16_90_1 e_1_2_16_132_1 e_1_2_16_155_1 e_1_2_16_178_1 Qi ZY (e_1_2_16_57_1) 2006; 25 e_1_2_16_193_1 e_1_2_16_170_1 e_1_2_16_204_1 Liang PC (e_1_2_16_22_1) 1962; 81 e_1_2_16_48_1 e_1_2_16_63_1 e_1_2_16_86_1 e_1_2_16_115_1 e_1_2_16_138_1 e_1_2_16_40_1 e_1_2_16_164_1 e_1_2_16_187_1 e_1_2_16_141_1 e_1_2_16_13_1 e_1_2_16_36_1 e_1_2_16_59_1 e_1_2_16_103_1 e_1_2_16_97_1 e_1_2_16_51_1 e_1_2_16_126_1 e_1_2_16_149_1 e_1_2_16_7_1 e_1_2_16_198_1 e_1_2_16_175_1 Ferlay J (e_1_2_16_4_1) 2018 e_1_2_16_152_1 e_1_2_16_201_1 e_1_2_16_190_1 (e_1_2_16_25_1) 2019 Xu SK (e_1_2_16_47_1) 2019; 32 e_1_2_16_24_1 e_1_2_16_139_1 e_1_2_16_85_1 e_1_2_16_62_1 e_1_2_16_116_1 e_1_2_16_142_1 e_1_2_16_188_1 e_1_2_16_165_1 e_1_2_16_180_1 e_1_2_16_35_1 e_1_2_16_58_1 e_1_2_16_104_1 e_1_2_16_96_1 e_1_2_16_73_1 e_1_2_16_50_1 e_1_2_16_127_1 e_1_2_16_199_1 e_1_2_16_153_1 e_1_2_16_176_1 e_1_2_16_6_1 e_1_2_16_130_1 e_1_2_16_202_1 e_1_2_16_191_1 |
| References_xml | – volume: 109 issue: 4 year: 2017 article-title: Current State of PCR‐Based Epstein‐Barr Virus DNA Testing for Nasopharyngeal Cancer publication-title: Journal of the National Cancer Institute – volume: 110 start-page: 390 issue: 3 year: 2014 end-page: 7 – volume: 125 start-page: 79 issue: 1 year: 2019 end-page: 89 article-title: Proposed modifications and incorporation of plasma Epstein‐Barr virus DNA improve the TNM staging system for Epstein‐Barr virus‐related nasopharyngeal carcinoma publication-title: Cancer – volume: 83 start-page: 712 issue: 2 year: 2012 end-page: 9 article-title: Image guidance during head‐and‐neck cancer radiation therapy: analysis of alignment trends with in‐room cone‐beam computed tomography scans publication-title: International journal of radiation oncology, biology, physics – volume: 31 start-page: 346 issue: 3 year: 2009 end-page: 54 article-title: Comparison of 4 modalities for distant metastasis staging in endemic nasopharyngeal carcinoma publication-title: Head & neck – volume: 39 start-page: 704 issue: 7 year: 2021 end-page: 12 article-title: Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS‐02) publication-title: Journal of clinical oncology: official journal of the American Society of Clinical Oncology – volume: 141 start-page: 1265 issue: 6 year: 2017 end-page: 76 article-title: Cetuximab or nimotuzumab plus intensity‐modulated radiotherapy versus cisplatin plus intensity‐modulated radiotherapy for stage II‐IVb nasopharyngeal carcinoma publication-title: International journal of cancer – volume: 13 start-page: 141 issue: 1 year: 2018 article-title: Feasibility of ipsilateral lower neck sparing irradiation for unilateral or bilateral neck node‐negative nasopharyngeal carcinoma: systemic review and meta‐analysis of 2, 521 patients publication-title: Radiation oncology (London, England) – volume: 13 start-page: 37 issue: 1 year: 2008 end-page: 42 article-title: Capecitabine as salvage treatment in relapsed nasopharyngeal carcinoma: a phase II study publication-title: Journal of BUON: official journal of the Balkan Union of Oncology – volume: 81 start-page: 629 year: 1962 end-page: 58 article-title: The histopathologic classification, biologic characteristics and histogenesis of nasopharyngeal carcinomas publication-title: Chinese medical journal (Peking, China: 1932) – volume: 45 start-page: e53 issue: 4 year: 2018 end-page: e83 article-title: Tolerance limits and methodologies for IMRT measurement‐based verification QA: Recommendations of AAPM Task Group No. 218 publication-title: Medical physics – volume: 41 issue: 6 year: 2014 article-title: Dosimetric effects caused by couch tops and immobilization devices: report of AAPM Task Group 176 publication-title: Medical physics – volume: 398 start-page: 303 issue: 10297 year: 2021 end-page: 13 article-title: Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open‐label, parallel‐group, randomised, controlled, phase 3 trial publication-title: Lancet (London, England) – volume: 35 start-page: 498 issue: 5 year: 2017 end-page: 505 article-title: What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta‐Analysis publication-title: Journal of clinical oncology: official journal of the American Society of Clinical Oncology – volume: 102 start-page: 1188 issue: 15 year: 2010 end-page: 98 article-title: Randomized trial of radiotherapy plus concurrent‐adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma publication-title: Journal of the National Cancer Institute – volume: 29 start-page: 731 issue: 3 year: 2018 end-page: 6 article-title: A randomized trial of induction docetaxel‐cisplatin‐5FU followed by concomitant cisplatin‐RT versus concomitant cisplatin‐RT in nasopharyngeal carcinoma (GORTEC 2006‐02) publication-title: Annals of oncology: official journal of the European Society for Medical Oncology – volume: 24 start-page: 2131 issue: 8 year: 2013 end-page: 6 article-title: Long‐term follow‐up of a phase III study comparing radiotherapy with or without weekly oxaliplatin for locoregionally advanced nasopharyngeal carcinoma publication-title: Annals of oncology: official journal of the European Society for Medical Oncology – volume: 35 start-page: 4050 issue: 36 year: 2017 end-page: 6 article-title: Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death‐Ligand 1‐Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE‐028 Study publication-title: Journal of clinical oncology: official journal of the American Society of Clinical Oncology – volume: 37 start-page: 487 issue: 4 year: 2015 end-page: 92 article-title: Morbidities after maxillary swing nasopharyngectomy for recurrent nasopharyngeal carcinoma publication-title: Head & neck – year: 2018 article-title: Global Cancer Observatory: cancer today publication-title: Lyon, France: International Agency for Research on Cancer – volume: 118 start-page: 244 issue: 2 year: 2016 end-page: 50 article-title: Comparison of weekly versus triweekly cisplatin delivered concurrently with radiation therapy in patients with locally advanced nasopharyngeal cancer: A multicenter randomized phase II trial (KCSG‐HN10‐02) publication-title: Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology – volume: 10 start-page: 235 issue: 2 year: 1999 end-page: 7 article-title: Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma publication-title: Annals of oncology: official journal of the European Society for Medical Oncology – year: 2021 article-title: Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first‐line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN‐1st): a multicentre, randomised, double‐blind, phase 3 trial publication-title: The Lancet Oncology – volume: 69 start-page: 26 year: 2017 end-page: 32 article-title: Ten‐year survival outcomes for patients with nasopharyngeal carcinoma receiving intensity‐modulated radiotherapy: An analysis of 614 patients from a single center publication-title: Oral oncology – volume: 76 start-page: 163 issue: 903 year: 2003 end-page: 76 article-title: Commissioning and quality assurance of the Pinnacle(3) radiotherapy treatment planning system for external beam photons publication-title: The British journal of radiology – year: 2019 – volume: 377 start-page: 513 issue: 6 year: 2017 end-page: 22 – volume: 45 issue: 1 year: 2021 article-title: Two‐year outcome of concurrent chemoradiation with carboplatin with or without adjuvant carboplatin/fluorouracil in nasopharyngeal cancer: A multicenter randomized trial publication-title: Current problems in cancer – volume: 19 start-page: 461 issue: 4 year: 2018 end-page: 73 – volume: 17 start-page: 294 issue: 3 year: 2016 end-page: 303 article-title: Riis Østergaard L. Comparison of manual and automatic MR‐CT registration for radiotherapy of prostate cancer publication-title: Journal of applied clinical medical physics – volume: 381 start-page: 1124 issue: 12 year: 2019 end-page: 35 – volume: 121 start-page: 1328 issue: 8 year: 2015 end-page: 38 article-title: Preliminary results of trial NPC‐0501 evaluating the therapeutic gain by changing from concurrent‐adjuvant to induction‐concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinoma publication-title: Cancer – volume: 66 start-page: 115 issue: 2 year: 2016 end-page: 32 article-title: Cancer statistics in China, 2015 publication-title: CA Cancer J Clin – volume: 145 start-page: 295 issue: 1 year: 2019 end-page: 305 article-title: Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long‐term results of phase 3 randomized controlled trial publication-title: International journal of cancer – volume: 71 start-page: 1356 issue: 5 year: 2008 end-page: 64 article-title: Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china publication-title: International journal of radiation oncology, biology, physics – volume: 126 start-page: 2163 issue: 10 year: 2020 end-page: 73 article-title: Prognostic potential of liquid biopsy tracking in the posttreatment surveillance of patients with nonmetastatic nasopharyngeal carcinoma publication-title: Cancer – volume: 14 issue: 7 year: 2019 article-title: The effectiveness of intensity‐modulated radiation therapy versus 2D‐RT for the treatment of nasopharyngeal carcinoma: A systematic review and meta‐analysis publication-title: PloS one – volume: 48 start-page: 329 issue: 2 year: 2000 end-page: 37 article-title: Comparison of treatment plans involving intensity‐modulated radiotherapy for nasopharyngeal carcinoma publication-title: International journal of radiation oncology, biology, physics – volume: 119 start-page: 3170 issue: 17 year: 2013 end-page: 6 article-title: A randomized clinical trial comparing prophylactic upper versus whole‐neck irradiation in the treatment of patients with node‐negative nasopharyngeal carcinoma publication-title: Cancer – volume: 19 start-page: 1338 issue: 10 year: 2018 end-page: 50 article-title: Camrelizumab (SHR‐1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single‐arm, phase 1 trials publication-title: The Lancet Oncology – volume: 51 start-page: 4841 issue: 19 year: 2006 end-page: 56 article-title: Dose variations with varying calculation grid size in head and neck IMRT publication-title: Physics in medicine and biology – volume: 115 start-page: 407 issue: 3 year: 2015 end-page: 11 article-title: Multi‐subject atlas‐based auto‐segmentation reduces interobserver variation and improves dosimetric parameter consistency for organs at risk in nasopharyngeal carcinoma: A multi‐institution clinical study publication-title: Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology – volume: 291 start-page: 677 issue: 3 year: 2019 end-page: 86 article-title: Deep Learning for Automated Contouring of Primary Tumor Volumes by MRI for Nasopharyngeal Carcinoma publication-title: Radiology – volume: 84 start-page: 283 issue: 1 year: 2012 end-page: 8 article-title: Do we need daily image‐guided radiotherapy by megavoltage computed tomography in head and neck helical tomotherapy? The actual delivered dose to the spinal cord publication-title: International journal of radiation oncology, biology, physics – volume: 103 start-page: 1761 issue: 23 year: 2011 end-page: 70 article-title: Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial publication-title: Journal of the National Cancer Institute – volume: 25 start-page: 4873 issue: 31 year: 2007 end-page: 9 article-title: Prospective randomized study of intensity‐modulated radiotherapy on salivary gland function in early‐stage nasopharyngeal carcinoma patients publication-title: Journal of clinical oncology: official journal of the American Society of Clinical Oncology – volume: 22 start-page: 381 issue: 3 year: 2021 end-page: 90 article-title: Endoscopic surgery compared with intensity‐modulated radiotherapy in resectable locally recurrent nasopharyngeal carcinoma: a multicentre, open‐label, randomised, controlled, phase 3 trial publication-title: The Lancet Oncology – volume: 117 start-page: 1743 issue: 12 year: 2017 end-page: 52 article-title: Systemic therapies for recurrent or metastatic nasopharyngeal carcinoma: a systematic review publication-title: British journal of cancer – volume: 25 start-page: 110 issue: 1 year: 2006 end-page: 4 article-title: Calibration of CT values used for radiation treatment planning and its impact factors publication-title: Ai zheng = Aizheng = Chinese journal of cancer – volume: 37 start-page: 1108 issue: 8 year: 2015 end-page: 15 article-title: Salvage endoscopic nasopharyngectomy and intensity‐modulated radiotherapy versus conventional radiotherapy in treating locally recurrent nasopharyngeal carcinoma publication-title: Head & neck – volume: 129 start-page: 387 issue: 2 year: 2019 end-page: 95 article-title: Surgery for isolated regional failure in nasopharyngeal carcinoma after radiation: Selective or comprehensive neck dissection publication-title: The Laryngoscope – volume: 51 start-page: 2587 issue: 17 year: 2015 end-page: 95 article-title: Intensity‐modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two‐dimensional radiotherapy: A 10‐year experience with a large cohort and long follow‐up publication-title: European journal of cancer (Oxford, England: 1990) – volume: 32 start-page: 452 issue: 4 year: 2021 end-page: 65 article-title: Nasopharyngeal carcinoma: ESMO‐EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow‐up(†) publication-title: Annals of oncology: official journal of the European Society for Medical Oncology – volume: 45 start-page: 1297 issue: 8 year: 2018 end-page: 308 – volume: 39 start-page: 361 issue: 4 year: 2003 end-page: 6 article-title: A phase II study of capecitabine in patients with recurrent and metastatic nasopharyngeal carcinoma pretreated with platinum‐based chemotherapy publication-title: Oral oncology – volume: 35 year: 2017 – volume: 10 year: 2020 article-title: Evaluation of the National Comprehensive Cancer Network and European Society for Medical Oncology Nasopharyngeal Carcinoma Surveillance Guidelines publication-title: Frontiers in oncology – volume: 98 issue: 24 year: 2019 article-title: Oncologic outcomes of IMRT versus CRT for nasopharyngeal carcinoma: A meta‐analysis publication-title: Medicine – volume: 117 start-page: 4452 issue: 19 year: 2011 end-page: 9 article-title: Plasma Epstein‐Barr virus DNA screening followed by ¹⁸F‐fluoro‐2‐deoxy‐D‐glucose positron emission tomography in detecting posttreatment failures of nasopharyngeal carcinoma publication-title: Cancer – volume: 10 year: 2020 article-title: Adding Concurrent Chemotherapy to Intensity‐Modulated Radiotherapy Does Not Improve Treatment Outcomes for Stage II Nasopharyngeal Carcinoma: A Phase 2 Multicenter Clinical Trial publication-title: Frontiers in oncology – volume: 100 start-page: 891 issue: 4 year: 2018 end-page: 902 article-title: Delineation of Neck Clinical Target Volume Specific to Nasopharyngeal Carcinoma Based on Lymph Node Distribution and the International Consensus Guidelines publication-title: International journal of radiation oncology, biology, physics – volume: 11 start-page: 6365 year: 2019 end-page: 76 article-title: Chinese expert consensus on diagnosis and treatment of nasopharyngeal carcinoma: evidence from current practice and future perspectives publication-title: Cancer management and research – volume: 18 start-page: 225 issue: 4 year: 2007 end-page: 35 article-title: Nasopharyngeal carcinoma: the role of magnetic resonance imaging in diagnosis, staging, treatment, and follow‐up publication-title: Topics in magnetic resonance imaging: TMRI – volume: 15 start-page: 8 year: 2020 end-page: 15 article-title: External validation of deep learning‐based contouring of head and neck organs at risk publication-title: Physics and imaging in radiation oncology – volume: 17 start-page: 1509 issue: 11 year: 2016 end-page: 20 article-title: Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial publication-title: The Lancet Oncology – volume: 47 start-page: 656 issue: 5 year: 2011 end-page: 66 article-title: Factors contributing to the efficacy of concurrent‐adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: combined analyses of NPC‐9901 and NPC‐9902 Trials publication-title: European journal of cancer (Oxford, England: 1990) – volume: 30 start-page: 1630 issue: 10 year: 2019 end-page: 7 article-title: Incidence and mortality of nasopharyngeal carcinoma: interim analysis of a cluster randomized controlled screening trial (PRO‐NPC‐001) in southern China publication-title: Annals of oncology: official journal of the European Society for Medical Oncology – volume: 126 start-page: 25 issue: 1 year: 2018 end-page: 36 – volume: 66 start-page: 142 issue: 1 year: 2006 end-page: 51 article-title: Preliminary results of a randomized study (NPC‐9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma publication-title: International journal of radiation oncology, biology, physics – volume: 68 start-page: 394 issue: 6 year: 2018 end-page: 424 article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA Cancer J Clin – volume: 16 start-page: 645 issue: 6 year: 2015 end-page: 55 – volume: 38 start-page: 1313 issue: 3 year: 2011 end-page: 38 article-title: Dosimetry tools and techniques for IMRT publication-title: Medical physics – volume: 8 start-page: 4532 issue: 11 year: 2016 end-page: 47 article-title: Comparison of MRI, CT and 18F‐FDG PET/CT in the diagnosis of local and metastatic of nasopharyngeal carcinomas: an updated meta analysis of clinical studies publication-title: American journal of translational research – volume: 6 issue: 95 year: 2011 article-title: Concurrent image‐guided intensity modulated radiotherapy and chemotherapy following neoadjuvant chemotherapy for locally advanced nasopharyngeal carcinoma publication-title: Radiation oncology (London, England) – volume: 71 start-page: 371 issue: 2 year: 2013 end-page: 8 article-title: Triplet combination with paclitaxel, cisplatin and 5‐FU is effective in metastatic and/or recurrent nasopharyngeal carcinoma publication-title: Cancer chemotherapy and pharmacology – volume: 24 start-page: 196 issue: 2 year: 2015 end-page: 9 article-title: The research of accuracy immobilized using individualized polyurethane scaling agent compared to positioning foam with standard plastics pillow in the radiotherapy of nasopharyngeal carcinoma publication-title: Chin J Radiat Oncol – volume: 388 start-page: 1883 issue: 10054 year: 2016 end-page: 92 article-title: Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open‐label, phase 3 trial publication-title: Lancet (London, England) – volume: 97 start-page: 536 issue: 7 year: 2005 end-page: 9 article-title: Overall survival after concurrent cisplatin‐radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma publication-title: Journal of the National Cancer Institute – volume: 64 start-page: 106 issue: 2 year: 2017 end-page: 13 – volume: 76 start-page: 1353 issue: 5 year: 2010 end-page: 9 article-title: Daily image guidance with cone‐beam computed tomography for head‐and‐neck cancer intensity‐modulated radiotherapy: a prospective study publication-title: International journal of radiation oncology, biology, physics – volume: 36 start-page: 87 issue: 1 year: 2017 article-title: Prognostic value of plasma Epstein‐Barr virus DNA level during posttreatment follow‐up in the patients with nasopharyngeal carcinoma having undergone intensity‐modulated radiotherapy publication-title: Chinese journal of cancer – volume: 51 start-page: 982 issue: 3 year: 2019 end-page: 91 article-title: Risk Assessment of Secondary Primary Malignancies in Nasopharyngeal Carcinoma: A Big‐Data Intelligence Platform‐Based Analysis of 6,377 Long‐term Survivors from an Endemic Area Treated with Intensity‐Modulated Radiation Therapy during 2003‐2013 publication-title: Cancer research and treatment – volume: 94 start-page: 80 year: 2019 end-page: 5 article-title: Cost‐effectiveness analysis of gemcitabine plus cisplatin versus fluorouracil plus cisplatin for first‐line treatment of recurrent or metastatic nasopharyngeal carcinoma publication-title: Oral oncology – volume: 62 start-page: 539 issue: 3 year: 2008 end-page: 44 article-title: Phase II study of capecitabine and cisplatin combination as first‐line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma publication-title: Cancer chemotherapy and pharmacology – start-page: 31 year: 2020 – volume: 129 start-page: 389 issue: 2 year: 2018 end-page: 95 – volume: 94 start-page: 850 issue: 4 year: 2016 end-page: 7 article-title: Image Guided Radiation Therapy (IGRT) Practice Patterns and IGRT's Impact on Workflow and Treatment Planning: Results From a National Survey of American Society for Radiation Oncology Members publication-title: International journal of radiation oncology – volume: 6 start-page: 201 issue: 11 year: 2018 article-title: The efficacy of first‐line chemotherapy in recurrent or metastatic nasopharyngeal carcinoma: a systematic review and meta‐analysis publication-title: Annals of translational medicine – volume: 119 start-page: 87 year: 2019 end-page: 96 article-title: Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long‐term results of a phase III multicentre randomised controlled trial publication-title: European journal of cancer (Oxford, England: 1990) – volume: 47 start-page: 626 issue: 2 year: 2020 end-page: 42 article-title: Patch‐based generative adversarial neural network models for head and neck MR‐only planning publication-title: Medical physics – volume: 110 start-page: 24 year: 2019 end-page: 31 article-title: Ten‐year outcomes of survival and toxicity for a phase III randomised trial of concurrent chemoradiotherapy versus radiotherapy alone in stage II nasopharyngeal carcinoma publication-title: European journal of cancer (Oxford, England: 1990) – year: 2021 article-title: Toripalimab or placebo plus chemotherapy as first‐line treatment in advanced nasopharyngeal carcinoma: a multi‐center randomized phase 3 trial publication-title: Nat Med – volume: 115 start-page: 680 issue: 3 year: 2009 end-page: 8 article-title: The volume to be irradiated during selective neck irradiation in nasopharyngeal carcinoma: analysis of the spread patterns in lymph nodes by magnetic resonance imaging publication-title: Cancer – volume: 51 start-page: 1760 issue: 13 year: 2015 end-page: 70 article-title: Ten‐year outcomes of a randomised trial for locoregionally advanced nasopharyngeal carcinoma: A single‐institution experience from an endemic area publication-title: European journal of cancer (Oxford, England: 1990) – volume: 10 start-page: 89 year: 2015 article-title: A retrospective study of the prognostic value of MRI‐derived residual tumors at the end of intensity‐modulated radiotherapy in 358 patients with locally‐advanced nasopharyngeal carcinoma publication-title: Radiation oncology (London, England) – volume: 16 start-page: 1310 issue: 4 year: 1998 end-page: 7 article-title: Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099 publication-title: Journal of clinical oncology: official journal of the American Society of Clinical Oncology – volume: 13 issue: 3 year: 2018 article-title: The role of concurrent chemotherapy for stage II nasopharyngeal carcinoma in the intensity‐modulated radiotherapy era: A systematic review and meta‐analysis publication-title: PloS one – volume: 36 start-page: 891 issue: 9 year: 2018 end-page: 9 article-title: Prognostic Model for Stratification of Radioresistant Nasopharynx Carcinoma to Curative Salvage Radiotherapy publication-title: Journal of clinical oncology: official journal of the American Society of Clinical Oncology – volume: 7 start-page: 2314 issue: 8 year: 2017 end-page: 24 article-title: Concurrent Chemoradiotherapy with or without Anti‐EGFR‐Targeted Treatment for Stage II‐IVb Nasopharyngeal Carcinoma: Retrospective Analysis with a Large Cohort and Long Follow‐up publication-title: Theranostics – volume: 75 start-page: 14 year: 2017 end-page: 23 article-title: Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial publication-title: European journal of cancer (Oxford, England: 1990) – volume: 83 start-page: 1344 issue: 4 year: 2012 end-page: 9 article-title: Standardizing naming conventions in radiation oncology publication-title: International journal of radiation oncology – volume: 112 start-page: 1877 issue: 10 year: 2002 end-page: 82 article-title: Nasopharyngectomy for recurrent nasopharyngeal carcinoma: a review of 31 patients and prognostic factors publication-title: The Laryngoscope – volume: 387 start-page: 1012 issue: 10022 year: 2016 end-page: 24 article-title: Nasopharyngeal carcinoma publication-title: Lancet (London, England) – volume: 7 start-page: 4825 issue: 19 year: 2017 end-page: 35 article-title: The Changing Therapeutic Role of Chemo‐radiotherapy for Loco‐regionally Advanced Nasopharyngeal Carcinoma from Two/Three‐Dimensional Radiotherapy to Intensity‐Modulated Radiotherapy: A Network Meta‐Analysis publication-title: Theranostics – volume: 43 start-page: 1399 issue: 9 year: 2007 end-page: 406 article-title: Chemoradiation comparing cisplatin versus carboplatin in locally advanced nasopharyngeal cancer: randomised, non‐inferiority, open trial publication-title: European journal of cancer (Oxford, England: 1990) – volume: 130 start-page: S59 issue: S2 year: 2016 end-page: s65 article-title: Pathological aspects of the assessment of head and neck cancers: United Kingdom National Multidisciplinary Guidelines publication-title: The Journal of laryngology and otology – volume: 34 start-page: 1383 issue: 10 year: 2012 end-page: 8 article-title: Use of a posterior pedicle nasal septum and floor mucoperiosteum flap to resurface the nasopharynx after endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma publication-title: Head & neck – volume: 38 start-page: 466 issue: 5 year: 1996 end-page: 70 article-title: Phase II study of the combination of carboplatin and 5‐fluorouracil in metastatic nasopharyngeal carcinoma publication-title: Cancer chemotherapy and pharmacology – volume: 46 start-page: 4095 issue: 9 year: 2019 end-page: 104 article-title: Dosimetric evaluation of synthetic CT for head and neck radiotherapy generated by a patch‐based three‐dimensional convolutional neural network publication-title: Medical physics – volume: 62 start-page: 501 issue: 2 year: 2005 end-page: 7 article-title: Nasopharyngeal carcinoma staging by (18)F‐fluorodeoxyglucose positron emission tomography publication-title: International journal of radiation oncology – volume: 35 start-page: 41 year: 2016 article-title: A new prognostic histopathologic classification of nasopharyngeal carcinoma publication-title: Chinese journal of cancer – volume: 21 start-page: 1369 issue: 11 year: 2016 end-page: 76 article-title: Prognostic Value of the Cumulative Cisplatin Dose During Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Secondary Analysis of a Prospective Phase III Clinical Trial publication-title: The oncologist – volume: 27 start-page: 397 issue: 5 year: 2005 end-page: 405 article-title: Survival outcome of patients with nasopharyngeal carcinoma with first local failure: a study by the Hong Kong Nasopharyngeal Carcinoma Study Group publication-title: Head & neck – volume: 39 start-page: 840 issue: 7 year: 2021 end-page: 59 article-title: Chemotherapy in Combination With Radiotherapy for Definitive‐Intent Treatment of Stage II‐IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline publication-title: Journal of clinical oncology: official journal of the American Society of Clinical Oncology – volume: 123 start-page: 4147 issue: 21 year: 2017 end-page: 57 article-title: A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10‐year outcomes for efficacy and toxicity publication-title: Cancer – volume: 96 start-page: 100 issue: 1 year: 2010 end-page: 3 – volume: 26 start-page: 205 issue: 1 year: 2015 end-page: 11 article-title: A Bayesian network meta‐analysis comparing concurrent chemoradiotherapy followed by adjuvant chemotherapy, concurrent chemoradiotherapy alone and radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma publication-title: Annals of oncology: official journal of the European Society for Medical Oncology – volume: 100 start-page: 1429 issue: 7 year: 2004 end-page: 37 article-title: Comparison of clinical and molecular surveillance in patients with advanced nasopharyngeal carcinoma after primary therapy: the potential role of quantitative analysis of circulating Epstein‐Barr virus DNA publication-title: Cancer – volume: 20 start-page: 2038 issue: 8 year: 2002 end-page: 44 article-title: Concurrent chemotherapy‐radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression‐free survival analysis of a phase III randomized trial publication-title: Journal of clinical oncology: official journal of the American Society of Clinical Oncology – volume: 48 start-page: 3198 issue: 17 year: 2012 end-page: 204 article-title: A prospective multicentre phase II study of cisplatin and weekly docetaxel as first‐line treatment for recurrent or metastatic nasopharyngeal cancer (KCSG HN07‐01) publication-title: European journal of cancer (Oxford, England: 1990) – volume: 28 start-page: 74 issue: 1 year: 2006 end-page: 80 article-title: Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin‐resistant nasopharyngeal carcinoma publication-title: Head & neck – volume: 56 start-page: 97 issue: 1 year: 2000 end-page: 108 article-title: Dosimetric effects of patient displacement and collimator and gantry angle misalignment on intensity modulated radiation therapy publication-title: Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology – volume: 15 start-page: 709 year: 2015 article-title: Investigation of the feasibility of elective irradiation to neck level Ib using intensity‐modulated radiotherapy for patients with nasopharyngeal carcinoma: a retrospective analysis publication-title: BMC cancer – volume: 32 start-page: 528 issue: 6 year: 2019 end-page: 32 article-title: Setup errors in the applications of two immbolization techniques in neck irradiation publication-title: J Cancer Control Treat – volume: 10 start-page: 365 issue: 3 year: 2010 end-page: 75 – volume: 79 year: 2019 article-title: Management of locally recurrent nasopharyngeal carcinoma publication-title: Cancer treatment reviews – volume: 128 start-page: 473 issue: 4 year: 2008 end-page: 81 article-title: Nasopharyngectomy for recurrent nasopharyngeal carcinoma: a review of 53 patients and prognostic factors publication-title: Acta oto‐laryngologica – volume: 23 start-page: 1118 issue: 6 year: 2005 end-page: 24 article-title: Long‐term survival after cisplatin‐based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials publication-title: Journal of clinical oncology: official journal of the American Society of Clinical Oncology – volume: 104 start-page: 324 issue: 3 year: 2012 end-page: 30 article-title: Volumetric modulated arc therapy for nasopharyngeal carcinoma: a dosimetric comparison with TomoTherapy and step‐and‐shoot IMRT publication-title: Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology – volume: 49 start-page: 620 issue: 6 year: 2013 end-page: 5 article-title: Clinical scenario of EBV DNA follow‐up in patients of treated localized nasopharyngeal carcinoma publication-title: Oral oncology – volume: 138 start-page: 1717 issue: 10 year: 2012 end-page: 25 article-title: Comparison of five cisplatin‐based regimens frequently used as the first‐line protocols in metastatic nasopharyngeal carcinoma publication-title: Journal of cancer research and clinical oncology – volume: 36 start-page: 468 issue: 4 year: 2014 end-page: 73 article-title: Treatment outcomes and feasibility of partial neck irradiation for patients with nasopharyngeal carcinoma with only retropharyngeal lymph node metastasis after intensity‐modulated radiotherapy publication-title: Head & neck – volume: 61 start-page: 33 issue: 1 year: 2008 end-page: 8 article-title: Phase II clinical study of gemcitabine in the treatment of patients with advanced nasopharyngeal carcinoma after the failure of platinum‐based chemotherapy publication-title: Cancer chemotherapy and pharmacology – volume: 61 start-page: 779 issue: 3 year: 2005 end-page: 88 article-title: The impact of daily setup variations on head‐and‐neck intensity‐modulated radiation therapy publication-title: International journal of radiation oncology, biology, physics – volume: 8 start-page: 4117 issue: 19 year: 2017 end-page: 23 article-title: Advantage of PET/CT in Target Delineation of MRI‐negative Cervical Lymph Nodes In Intensity‐Modulated Radiation Therapy Planning for Nasopharyngeal Carcinoma publication-title: Journal of Cancer – volume: 27 start-page: 3684 issue: 22 year: 2009 end-page: 90 article-title: Intensity‐modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225 publication-title: Journal of clinical oncology: official journal of the American Society of Clinical Oncology – volume: 110 start-page: 297 issue: 2 year: 2014 end-page: 303 article-title: Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity‐modulated radiotherapy publication-title: British journal of cancer – volume: 8 start-page: 861 issue: 5 year: 2017 end-page: 9 article-title: Magnetic Resonance Imaging‐Detected Tumor Residue after Intensity‐Modulated Radiation Therapy and its Association with Post‐Radiation Plasma Epstein‐Barr Virus Deoxyribonucleic Acid in Nasopharyngeal Carcinoma publication-title: Journal of Cancer – volume: 109 start-page: 1609 issue: 5 year: 2018 end-page: 16 article-title: Anti‐epidermal growth factor receptor therapy concurrently with induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma publication-title: Cancer science – volume: 21 start-page: 317 issue: 6 year: 2013 end-page: 23 article-title: A phase II trial of Endostar combined with gemcitabine and cisplatin chemotherapy in patients with metastatic nasopharyngeal carcinoma (NCT01612286) publication-title: Oncology research – volume: 142 start-page: 115 year: 2020 end-page: 23 article-title: Improving automatic delineation for head and neck organs at risk by Deep Learning Contouring publication-title: Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology – volume: 75 start-page: 742 issue: 3 year: 2009 end-page: 50 article-title: Extension of local disease in nasopharyngeal carcinoma detected by magnetic resonance imaging: improvement of clinical target volume delineation publication-title: International journal of radiation oncology, biology, physics – volume: 13 start-page: 163 issue: 2 year: 2012 end-page: 71 – volume: 22 start-page: 718 issue: 3 year: 2011 end-page: 22 article-title: Docetaxel is effective in heavily pretreated patients with disseminated nasopharyngeal carcinoma publication-title: Annals of oncology: official journal of the European Society for Medical Oncology – volume: 81 start-page: 943 issue: 4 year: 2011 end-page: 9 article-title: Evaluation of the planning target volume in the treatment of head and neck cancer with intensity‐modulated radiotherapy: what is the appropriate expansion margin in the setting of daily image guidance? publication-title: International journal of radiation oncology – volume: 51 start-page: 1771 issue: 13 year: 2015 end-page: 9 article-title: New surgical staging system for patients with recurrent nasopharyngeal carcinoma based on the AJCC/UICC rTNM classification system publication-title: European journal of cancer (Oxford, England: 1990) – volume: 374 start-page: 22 issue: 1 year: 2016 end-page: 30 – year: 2018 article-title: Analysis of Plasma Epstein‐Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High‐Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial publication-title: Journal of clinical oncology: official journal of the American Society of Clinical Oncology – volume: 104 start-page: 286 issue: 3 year: 2012 end-page: 93 article-title: A prospective, randomized study comparing outcomes and toxicities of intensity‐modulated radiotherapy vs. conventional two‐dimensional radiotherapy for the treatment of nasopharyngeal carcinoma publication-title: Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology – volume: 36 start-page: 1412 issue: 14 year: 2018 end-page: 8 article-title: Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI‐9742) publication-title: Journal of clinical oncology: official journal of the American Society of Clinical Oncology – volume: 50 start-page: 539 issue: 6 year: 2014 end-page: 48 article-title: Updates on MR imaging and ¹⁸F‐FDG PET/CT imaging in nasopharyngeal carcinoma publication-title: Oral oncology – volume: 35 start-page: 103 issue: 1 year: 2016 article-title: Prognostic factors and failure patterns in non‐metastatic nasopharyngeal carcinoma after intensity‐modulated radiotherapy publication-title: Chinese journal of cancer – volume: 115 start-page: 399 issue: 3 year: 2015 end-page: 406 article-title: Salvage endoscopic nasopharyngectomy is superior to intensity‐modulated radiation therapy for local recurrence of selected T1‐T3 nasopharyngeal carcinoma – A case‐matched comparison publication-title: Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology – volume: 105 start-page: 581 issue: 3 year: 2019 end-page: 90 article-title: The Association Between the Development of Radiation Therapy, Image Technology, and Chemotherapy, and the Survival of Patients With Nasopharyngeal Carcinoma: A Cohort Study From 1990 to 2012 publication-title: International journal of radiation oncology, biology, physics – volume: 104 start-page: 836 issue: 4 year: 2019 end-page: 44 article-title: Locoregional Control and Mild Late Toxicity After Reducing Target Volumes and Radiation Doses in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Treated With Induction Chemotherapy (IC) Followed by Concurrent Chemoradiotherapy: 10‐Year Results of a Phase 2 Study publication-title: International journal of radiation oncology, biology, physics – volume: 126 start-page: 37 issue: 1 year: 2018 end-page: 42 – start-page: S36 year: 2006 end-page: 49 article-title: Localization: conventional and CT simulation publication-title: The British journal of radiology – volume: 96 start-page: 126 issue: 2 year: 2001 end-page: 31 article-title: Comparison of intensity modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma publication-title: International journal of cancer – volume: 47 start-page: 1880 issue: 4 year: 2020 end-page: 94 article-title: Multi‐sequence MR image‐based synthetic CT generation using a generative adversarial network for head and neck MRI‐only radiotherapy publication-title: Medical physics – volume: 19 start-page: 998 issue: 6 year: 2014 end-page: 1004 article-title: Sparing level Ib lymph nodes by intensity‐modulated radiotherapy in the treatment of nasopharyngeal carcinoma publication-title: International journal of clinical oncology – volume: 69 start-page: 68 year: 2017 end-page: 73 article-title: The feasibility of contralateral lower neck sparing intensity modulation radiated therapy for nasopharyngeal carcinoma patients with unilateral cervical lymph node involvement publication-title: Oral oncology – volume: 11 start-page: 3872 issue: 1 year: 2020 article-title: An optimal posttreatment surveillance strategy for cancer survivors based on an individualized risk‐based approach publication-title: Nature communications – volume: 102 start-page: 1382 issue: 4 year: 2018 end-page: 91 article-title: Cost‐Effectiveness Analysis of Routine Magnetic Resonance Imaging in the Follow‐Up of Patients With Nasopharyngeal Carcinoma After Intensity Modulated Radiation Therapy publication-title: International journal of radiation oncology, biology, physics – volume: 82 start-page: 1 year: 2018 end-page: 7 article-title: Interobserver variations in the delineation of target volumes and organs at risk and their impact on dose distribution in intensity‐modulated radiation therapy for nasopharyngeal carcinoma publication-title: Oral oncology – volume: 105 start-page: 567 issue: 3 year: 2019 end-page: 80 article-title: International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma publication-title: International journal of radiation oncology, biology, physics – volume: 72 start-page: 1368 issue: 5 year: 2008 end-page: 77 article-title: How does magnetic resonance imaging influence staging according to AJCC staging system for nasopharyngeal carcinoma compared with computed tomography? publication-title: International journal of radiation oncology, biology, physics – volume: 16 start-page: 464 year: 2016 article-title: Phase I/II dose‐finding study of nanoparticle albumin‐bound paclitaxel (nab®‐Paclitaxel) plus Cisplatin as Treatment for Metastatic Nasopharyngeal Carcinoma publication-title: BMC cancer – volume: 14 start-page: 182 issue: 1 year: 2019 article-title: Maintenance chemotherapy using S‐1 following definitive chemoradiotherapy in patients with N3 nasopharyngeal carcinoma publication-title: Radiation oncology (London, England) – volume: 24 start-page: 1824 issue: 8 year: 2018 end-page: 33 article-title: Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized Trials publication-title: Clinical cancer research: an official journal of the American Association for Cancer Research – volume: 36 start-page: 95 issue: 1 year: 2017 article-title: Significant value of (18)F‐FDG‐PET/CT in diagnosing small cervical lymph node metastases in patients with nasopharyngeal carcinoma treated with intensity‐modulated radiotherapy publication-title: Chinese journal of cancer – volume: 1 start-page: 1 year: 2017 end-page: 7 – volume: 5 start-page: 87 issue: 1 year: 1994 end-page: 9 article-title: A phase II trial of 5‐fluorouracil and cisplatinum in recurrent or metastatic nasopharyngeal carcinoma publication-title: Annals of oncology: official journal of the European Society for Medical Oncology – volume: 126 start-page: 3674 issue: 16 year: 2020 end-page: 88 article-title: NPC‐0501 trial on the value of changing chemoradiotherapy sequence, replacing 5‐fluorouracil with capecitabine, and altering fractionation for patients with advanced nasopharyngeal carcinoma publication-title: Cancer – volume: 150 start-page: 217 year: 2020 end-page: 24 article-title: Magnetic resonance‐based synthetic computed tomography images generated using generative adversarial networks for nasopharyngeal carcinoma radiotherapy treatment planning publication-title: Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology – volume: 9 year: 2014 article-title: Local failure patterns for patients with nasopharyngeal carcinoma after intensity‐modulated radiotherapy publication-title: Radiation oncology (London, England) – volume: 104 start-page: 677 issue: 3 year: 2019 end-page: 84 article-title: Deep Learning‐Based Delineation of Head and Neck Organs at Risk: Geometric and Dosimetric Evaluation publication-title: International journal of radiation oncology, biology, physics – volume: 51 start-page: 1570 issue: 12 year: 2015 end-page: 9 article-title: Chemoradiotherapy regimens for locoregionally advanced nasopharyngeal carcinoma: A Bayesian network meta‐analysis publication-title: European journal of cancer (Oxford, England: 1990) – volume: 77 start-page: 1397 issue: 5 year: 2010 end-page: 402 article-title: Is elective irradiation to the lower neck necessary for N0 nasopharyngeal carcinoma? publication-title: International journal of radiation oncology, biology, physics – volume: 32 start-page: 380 issue: 2 year: 2005 end-page: 8 article-title: A fourier analysis of the dose grid resolution required for accurate IMRT fluence map optimization publication-title: Medical physics – volume: 64 start-page: 15 year: 2017 end-page: 21 article-title: Prognostic impact of adjuvant chemotherapy in high‐risk nasopharyngeal carcinoma patients publication-title: Oral oncology – volume: 249 start-page: 203 issue: 1 year: 2008 end-page: 11 article-title: Detection and restaging of residual and/or recurrent nasopharyngeal carcinoma after chemotherapy and radiation therapy: comparison of MR imaging and FDG PET/CT publication-title: Radiology – volume: 70 start-page: 1256 issue: 4 year: 2008 end-page: 62 article-title: Actual dose variation of parotid glands and spinal cord for nasopharyngeal cancer patients during radiotherapy publication-title: International journal of radiation oncology – volume: 32 start-page: 245 issue: 1 year: 1995 end-page: 8 article-title: A customized head and neck support system publication-title: International journal of radiation oncology, biology, physics – volume: 7 start-page: 86914 issue: 52 year: 2016 end-page: 25 article-title: Investigation of long‐term survival outcomes and failure patterns of patients with nasopharyngeal carcinoma receiving intensity‐modulated radiotherapy: a retrospective analysis publication-title: Oncotarget – volume: 38 Suppl 1 start-page: E2130 year: 2016 end-page: 42 article-title: Evidence on effectiveness of intensity‐modulated radiotherapy versus 2‐dimensional radiotherapy in the treatment of nasopharyngeal carcinoma: Meta‐analysis and a systematic review of the literature publication-title: Head & neck – volume: 27 start-page: 242 issue: 2 year: 2009 end-page: 9 article-title: Randomized phase II trial of concurrent cisplatin‐radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma publication-title: Journal of clinical oncology: official journal of the American Society of Clinical Oncology – volume: 83 start-page: 676 issue: 2 year: 2012 end-page: 83 article-title: Intensity‐modulated radiation therapy in the salvage of locally recurrent nasopharyngeal carcinoma publication-title: International journal of radiation oncology – volume: 66 start-page: 981 issue: 4 year: 2006 end-page: 91 article-title: Xerostomia and quality of life after intensity‐modulated radiotherapy vs. conventional radiotherapy for early‐stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial publication-title: International journal of radiation oncology, biology, physics – volume: 23 start-page: 8461 issue: 33 year: 2005 end-page: 8 article-title: Phase III study comparing standard radiotherapy with or without weekly oxaliplatin in treatment of locoregionally advanced nasopharyngeal carcinoma: preliminary results publication-title: Journal of clinical oncology: official journal of the American Society of Clinical Oncology – volume: 31 start-page: 2861 issue: 23 year: 2013 end-page: 9 article-title: Prospective study of tailoring whole‐body dual‐modality [18F]fluorodeoxyglucose positron emission tomography/computed tomography with plasma Epstein‐Barr virus DNA for detecting distant metastasis in endemic nasopharyngeal carcinoma at initial staging publication-title: Journal of clinical oncology: official journal of the American Society of Clinical Oncology – volume: 101 start-page: 1078 issue: 5 year: 2018 end-page: 86 article-title: Concurrent‐Adjuvant Chemoradiation Therapy for Stage III‐IVB Nasopharyngeal Carcinoma‐Exploration for Achieving Optimal 10‐Year Therapeutic Ratio publication-title: International journal of radiation oncology, biology, physics – volume: 75 start-page: 150 year: 2017 end-page: 8 article-title: Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Long‐term results of a phase 3 multicentre randomised controlled trial publication-title: European journal of cancer (Oxford, England: 1990) – volume: 6 start-page: 1345 issue: 9 year: 2020 end-page: 52 article-title: Efficacy and Safety of Locoregional Radiotherapy With Chemotherapy vs Chemotherapy Alone in De Novo Metastatic Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical Trial publication-title: JAMA oncology – volume: 110 start-page: 398 issue: 3 year: 2014 end-page: 403 article-title: Long‐term outcomes of intensity‐modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities publication-title: Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology – volume: 93 start-page: 530 issue: 3 year: 2009 end-page: 3 article-title: A study of middle ear function in the treatment of nasopharyngeal carcinoma with IMRT technique publication-title: Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology – volume: 23 start-page: 6730 issue: 27 year: 2005 end-page: 8 article-title: Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety publication-title: Journal of clinical oncology: official journal of the American Society of Clinical Oncology – volume: 48 start-page: 1146 issue: 11 year: 2012 end-page: 51 article-title: Salvage gemcitabine‐vinorelbine chemotherapy in patients with metastatic nasopharyngeal carcinoma pretreated with platinum‐based chemotherapy publication-title: Oral oncology – volume: 10 year: 2020 article-title: Quality of Life, Toxicity and Unmet Needs in Nasopharyngeal Cancer Survivors publication-title: Frontiers in oncology – volume: 394 start-page: 64 issue: 10192 year: 2019 end-page: 80 article-title: Nasopharyngeal carcinoma publication-title: Lancet (London, England) – year: 2017 – volume: 74 start-page: 252 issue: 1 year: 2009 end-page: 9 article-title: Volumetric intensity‐modulated arc therapy vs. conventional IMRT in head‐and‐neck cancer: a comparative planning and dosimetric study publication-title: International journal of radiation oncology, biology, physics – volume: 98 start-page: 283 issue: 2 year: 2003 end-page: 7 article-title: 18‐fluoro‐2‐deoxyglucose positron emission tomography in detecting residual/recurrent nasopharyngeal carcinomas and comparison with magnetic resonance imaging publication-title: Cancer – volume: 52 start-page: 3679 issue: 13 year: 2007 end-page: 91 article-title: Collapsed cone convolution and analytical anisotropic algorithm dose calculations compared to VMC++ Monte Carlo simulations in clinical cases publication-title: Physics in medicine and biology – volume: 65 start-page: 87 issue: 2 year: 2015 end-page: 108 article-title: Global cancer statistics, 2012 publication-title: CA Cancer J Clin – volume: 103 start-page: 576 issue: 3 year: 2005 end-page: 81 article-title: Phase II study of irinotecan (CPT‐11) as salvage therapy for advanced nasopharyngeal carcinoma publication-title: Cancer – ident: e_1_2_16_114_1 doi: 10.1016/S0140-6736(21)01123-5 – ident: e_1_2_16_155_1 doi: 10.1007/s00280-007-0641-2 – ident: e_1_2_16_197_1 – ident: e_1_2_16_143_1 doi: 10.1634/theoncologist.2016-0105 – ident: e_1_2_16_141_1 doi: 10.1200/JCO.2017.35.15_suppl.6006 – volume: 13 start-page: 37 issue: 1 year: 2008 ident: e_1_2_16_159_1 article-title: Capecitabine as salvage treatment in relapsed nasopharyngeal carcinoma: a phase II study publication-title: Journal of BUON: official journal of the Balkan Union of Oncology – ident: e_1_2_16_30_1 doi: 10.1002/cncr.31741 – ident: e_1_2_16_201_1 doi: 10.1186/s40880-016-0167-2 – ident: e_1_2_16_73_1 doi: 10.1016/j.ijrobp.2009.03.059 – ident: e_1_2_16_189_1 doi: 10.1080/00016480701813806 – volume: 25 start-page: 110 issue: 1 year: 2006 ident: e_1_2_16_57_1 article-title: Calibration of CT values used for radiation treatment planning and its impact factors publication-title: Ai zheng = Aizheng = Chinese journal of cancer – ident: e_1_2_16_158_1 doi: 10.1016/S1368-8375(02)00120-3 – ident: e_1_2_16_101_1 doi: 10.1016/j.ijrobp.2019.02.040 – ident: e_1_2_16_188_1 doi: 10.1097/00005537-200210000-00033 – ident: e_1_2_16_60_1 doi: 10.1259/bjr/42085182 – ident: e_1_2_16_181_1 doi: 10.1002/hed.23633 – ident: e_1_2_16_192_1 doi: 10.1016/j.ijrobp.2018.01.117 – ident: e_1_2_16_68_1 doi: 10.1002/mp.12810 – ident: e_1_2_16_157_1 doi: 10.3727/096504014X13983417587401 – ident: e_1_2_16_71_1 doi: 10.1016/j.ijrobp.2007.10.067 – year: 2018 ident: e_1_2_16_4_1 article-title: Global Cancer Observatory: cancer today publication-title: Lyon, France: International Agency for Research on Cancer – ident: e_1_2_16_18_1 doi: 10.3389/fonc.2020.00119 – ident: e_1_2_16_27_1 doi: 10.1056/NEJMoa1701717 – ident: e_1_2_16_119_1 doi: 10.1200/JCO.2004.00.3863 – ident: e_1_2_16_183_1 doi: 10.1002/hed.23719 – ident: e_1_2_16_6_1 doi: 10.3322/caac.21338 – ident: e_1_2_16_59_1 doi: 10.1118/1.1843354 – ident: e_1_2_16_144_1 doi: 10.1016/j.ijrobp.2018.04.069 – ident: e_1_2_16_85_1 doi: 10.1002/cncr.24049 – ident: e_1_2_16_91_1 doi: 10.1007/s10147-013-0650-6 – year: 2018 ident: e_1_2_16_123_1 article-title: Analysis of Plasma Epstein‐Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High‐Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial publication-title: Journal of clinical oncology: official journal of the American Society of Clinical Oncology – ident: e_1_2_16_52_1 doi: 10.1016/S0360-3016(00)00585-X – ident: e_1_2_16_133_1 doi: 10.1200/JCO.2016.67.4119 – ident: e_1_2_16_154_1 doi: 10.1023/A:1008390929826 – ident: e_1_2_16_166_1 doi: 10.1200/JCO.20.02712 – ident: e_1_2_16_14_1 doi: 10.1016/j.ijrobp.2004.09.057 – ident: e_1_2_16_54_1 doi: 10.1016/j.ijrobp.2008.12.033 – ident: e_1_2_16_137_1 doi: 10.1016/j.ejca.2016.12.039 – ident: e_1_2_16_61_1 doi: 10.1088/0031-9155/51/19/008 – ident: e_1_2_16_81_1 doi: 10.1016/j.ijrobp.2008.11.053 – volume: 6 issue: 95 year: 2011 ident: e_1_2_16_74_1 article-title: Concurrent image‐guided intensity modulated radiotherapy and chemotherapy following neoadjuvant chemotherapy for locally advanced nasopharyngeal carcinoma publication-title: Radiation oncology (London, England) – ident: e_1_2_16_75_1 doi: 10.1016/j.ijrobp.2011.10.073 – volume: 81 start-page: 629 year: 1962 ident: e_1_2_16_22_1 article-title: The histopathologic classification, biologic characteristics and histogenesis of nasopharyngeal carcinomas publication-title: Chinese medical journal (Peking, China: 1932) – ident: e_1_2_16_170_1 doi: 10.1038/bjc.2017.357 – ident: e_1_2_16_195_1 doi: 10.1002/cncr.30850 – ident: e_1_2_16_171_1 doi: 10.1007/s00432-012-1219-x – ident: e_1_2_16_53_1 doi: 10.1016/j.radonc.2013.10.020 – ident: e_1_2_16_187_1 doi: 10.1016/j.ijrobp.2011.07.006 – ident: e_1_2_16_196_1 doi: 10.1016/j.oraloncology.2017.03.015 – ident: e_1_2_16_191_1 doi: 10.1038/s41467-020-17672-w – ident: e_1_2_16_106_1 doi: 10.1200/JCO.2002.08.149 – ident: e_1_2_16_112_1 doi: 10.1200/JCO.2005.16.790 – ident: e_1_2_16_134_1 doi: 10.1016/j.ijrobp.2007.12.028 – ident: e_1_2_16_26_1 doi: 10.1093/annonc/mdz231 – ident: e_1_2_16_145_1 doi: 10.1016/j.ejca.2015.05.025 – ident: e_1_2_16_202_1 doi: 10.18632/oncotarget.13564 – ident: e_1_2_16_48_1 doi: 10.1259/bjr/17748030 – ident: e_1_2_16_62_1 doi: 10.1088/0031-9155/52/13/002 – ident: e_1_2_16_153_1 doi: 10.1016/j.ejca.2012.06.009 – ident: e_1_2_16_31_1 doi: 10.1016/j.radonc.2012.08.013 – ident: e_1_2_16_206_1 doi: 10.1002/cncr.20129 – ident: e_1_2_16_140_1 doi: 10.1016/j.radonc.2015.11.030 – ident: e_1_2_16_65_1 doi: 10.1002/mp.13663 – ident: e_1_2_16_83_1 doi: 10.1016/j.radonc.2017.10.032 – ident: e_1_2_16_193_1 doi: 10.1016/j.radonc.2018.09.004 – ident: e_1_2_16_177_1 doi: 10.1016/j.radonc.2015.04.024 – ident: e_1_2_16_63_1 doi: 10.1016/j.radonc.2020.06.049 – ident: e_1_2_16_37_1 doi: 10.1002/hed.23977 – ident: e_1_2_16_99_1 doi: 10.1016/j.phro.2020.06.006 – ident: e_1_2_16_160_1 doi: 10.1093/annonc/mdq425 – ident: e_1_2_16_38_1 doi: 10.3389/fonc.2020.00930 – ident: e_1_2_16_168_1 doi: 10.1200/JCO.2017.73.3675 – ident: e_1_2_16_20_1 doi: 10.1200/JCO.2012.46.0816 – ident: e_1_2_16_175_1 doi: 10.2147/CMAR.S197544 – ident: e_1_2_16_156_1 doi: 10.1186/s12885-016-2517-5 – ident: e_1_2_16_88_1 doi: 10.1002/cncr.28201 – ident: e_1_2_16_23_1 doi: 10.1186/s40880-016-0103-5 – ident: e_1_2_16_136_1 doi: 10.1200/JCO.2005.12.081 – ident: e_1_2_16_162_1 doi: 10.1002/hed.20310 – ident: e_1_2_16_2_1 doi: 10.1016/S0140-6736(15)00055-0 – ident: e_1_2_16_50_1 doi: 10.1016/0360-3016(94)00412-E – ident: e_1_2_16_107_1 doi: 10.1002/ijc.32099 – volume-title: National Comprehensive Cancer Network. NCCN clinical practice guidelines: head and neck cancers version 3, 2019 year: 2019 ident: e_1_2_16_25_1 – ident: e_1_2_16_77_1 doi: 10.1016/j.ijrobp.2011.08.001 – ident: e_1_2_16_87_1 doi: 10.1016/j.ijrobp.2009.06.062 – ident: e_1_2_16_24_1 doi: 10.1017/S0022215116000451 – ident: e_1_2_16_190_1 doi: 10.1016/j.annonc.2020.12.007 – ident: e_1_2_16_49_1 doi: 10.1120/jacmp.v17i3.6088 – ident: e_1_2_16_40_1 doi: 10.1200/JCO.2008.19.9109 – ident: e_1_2_16_66_1 doi: 10.1002/mp.13927 – ident: e_1_2_16_179_1 doi: 10.1038/bjc.2013.715 – ident: e_1_2_16_17_1 doi: 10.1148/radiol.2491071753 – ident: e_1_2_16_121_1 doi: 10.7150/thno.19710 – ident: e_1_2_16_173_1 doi: 10.1016/j.oraloncology.2019.04.022 – ident: e_1_2_16_19_1 doi: 10.1007/s00259-018-3986-3 – ident: e_1_2_16_130_1 doi: 10.1016/j.ejca.2015.04.027 – ident: e_1_2_16_76_1 doi: 10.1016/j.ijrobp.2015.09.035 – ident: e_1_2_16_127_1 doi: 10.1016/S1470-2045(15)70126-9 – ident: e_1_2_16_3_1 doi: 10.3322/caac.21492 – ident: e_1_2_16_34_1 doi: 10.1371/journal.pone.0194733 – ident: e_1_2_16_79_1 doi: 10.1016/j.radonc.2017.07.020 – ident: e_1_2_16_96_1 doi: 10.1016/j.radonc.2009.09.013 – ident: e_1_2_16_82_1 doi: 10.1016/j.ijrobp.2017.11.004 – ident: e_1_2_16_89_1 doi: 10.1186/s13014-018-1087-x – ident: e_1_2_16_117_1 – ident: e_1_2_16_13_1 doi: 10.1016/j.oraloncology.2013.05.005 – ident: e_1_2_16_41_1 doi: 10.7150/jca.17957 – ident: e_1_2_16_92_1 doi: 10.1148/radiol.2019182012 – ident: e_1_2_16_118_1 doi: 10.1093/annonc/mdt163 – ident: e_1_2_16_102_1 doi: 10.3322/caac.21262 – ident: e_1_2_16_147_1 doi: 10.1016/S1470-2045(21)00302-8 – volume: 24 start-page: 196 issue: 2 year: 2015 ident: e_1_2_16_45_1 article-title: The research of accuracy immobilized using individualized polyurethane scaling agent compared to positioning foam with standard plastics pillow in the radiotherapy of nasopharyngeal carcinoma publication-title: Chin J Radiat Oncol – ident: e_1_2_16_46_1 doi: 10.1002/jmrs.189 – ident: e_1_2_16_139_1 doi: 10.1093/annonc/mdx770 – ident: e_1_2_16_198_1 doi: 10.1186/1748-717X-9-87 – ident: e_1_2_16_95_1 doi: 10.1016/j.ijrobp.2011.09.054 – ident: e_1_2_16_126_1 doi: 10.3389/fonc.2020.01314 – ident: e_1_2_16_204_1 doi: 10.1002/cncr.26069 – ident: e_1_2_16_113_1 doi: 10.1093/jnci/djq258 – ident: e_1_2_16_148_1 doi: 10.1038/s41591-021-01444-0 – ident: e_1_2_16_161_1 doi: 10.1007/s00280-007-0441-8 – ident: e_1_2_16_28_1 doi: 10.1093/jnci/djx007 – ident: e_1_2_16_184_1 doi: 10.1002/hed.20161 – ident: e_1_2_16_44_1 doi: 10.1016/j.tipsro.2016.12.001 – ident: e_1_2_16_55_1 doi: 10.1016/j.radonc.2011.11.017 – ident: e_1_2_16_78_1 doi: 10.7150/jca.21582 – ident: e_1_2_16_151_1 doi: 10.1093/oxfordjournals.annonc.a058703 – ident: e_1_2_16_169_1 doi: 10.1016/j.annonc.2020.10.264 – ident: e_1_2_16_172_1 doi: 10.21037/atm.2018.05.14 – ident: e_1_2_16_174_1 doi: 10.1007/s00280-012-2020-x – ident: e_1_2_16_194_1 doi: 10.1016/j.ejca.2015.08.006 – ident: e_1_2_16_56_1 doi: 10.1002/ijc.1004 – ident: e_1_2_16_149_1 doi: 10.1016/S0140-6736(16)31388-5 – ident: e_1_2_16_9_1 doi: 10.1200/JCO.20.03237 – volume: 8 start-page: 4532 issue: 11 year: 2016 ident: e_1_2_16_12_1 article-title: Comparison of MRI, CT and 18F‐FDG PET/CT in the diagnosis of local and metastatic of nasopharyngeal carcinomas: an updated meta analysis of clinical studies publication-title: American journal of translational research – ident: e_1_2_16_110_1 doi: 10.1200/JCO.2008.18.1545 – ident: e_1_2_16_39_1 doi: 10.1200/JCO.1998.16.4.1310 – ident: e_1_2_16_207_1 doi: 10.4143/crt.2018.298 – ident: e_1_2_16_36_1 doi: 10.1097/MD.0000000000015951 – ident: e_1_2_16_163_1 doi: 10.1016/j.oraloncology.2012.05.021 – ident: e_1_2_16_104_1 doi: 10.1016/j.ejca.2018.10.020 – ident: e_1_2_16_109_1 doi: 10.1056/NEJMoa1905287 – ident: e_1_2_16_32_1 doi: 10.1200/JCO.2007.11.5501 – ident: e_1_2_16_120_1 doi: 10.1016/j.ejca.2007.03.022 – ident: e_1_2_16_69_1 doi: 10.1016/j.ijrobp.2004.07.696 – ident: e_1_2_16_115_1 doi: 10.1002/cncr.29208 – ident: e_1_2_16_21_1 doi: 10.1002/hed.20974 – ident: e_1_2_16_7_1 doi: 10.1016/j.canlet.2016.01.040 – ident: e_1_2_16_90_1 doi: 10.1016/j.oraloncology.2017.03.010 – ident: e_1_2_16_16_1 doi: 10.1002/cncr.11519 – ident: e_1_2_16_42_1 doi: 10.1186/s13014-015-0401-0 – ident: e_1_2_16_51_1 doi: 10.1016/j.radonc.2010.04.014 – ident: e_1_2_16_142_1 doi: 10.1016/j.ejca.2010.10.026 – ident: e_1_2_16_80_1 doi: 10.1016/j.ijrobp.2019.03.043 – ident: e_1_2_16_11_1 doi: 10.1016/j.ijrobp.2008.03.017 – ident: e_1_2_16_128_1 – ident: e_1_2_16_131_1 doi: 10.7150/thno.21815 – ident: e_1_2_16_152_1 doi: 10.1007/s002800050512 – ident: e_1_2_16_150_1 doi: 10.1001/jamaoncol.2020.1808 – ident: e_1_2_16_116_1 doi: 10.1111/cas.13589 – ident: e_1_2_16_129_1 doi: 10.1016/j.ejca.2017.01.002 – ident: e_1_2_16_43_1 doi: 10.1002/cncr.32972 – ident: e_1_2_16_203_1 doi: 10.1016/j.oraloncology.2013.02.006 – ident: e_1_2_16_108_1 doi: 10.1016/S1470-2045(16)30410-7 – ident: e_1_2_16_33_1 doi: 10.1016/j.ijrobp.2006.06.013 – ident: e_1_2_16_180_1 doi: 10.1016/S1470-2045(20)30673-2 – ident: e_1_2_16_100_1 doi: 10.1016/j.radonc.2019.09.022 – ident: e_1_2_16_10_1 doi: 10.1016/j.ijrobp.2019.06.2549 – volume: 32 start-page: 528 issue: 6 year: 2019 ident: e_1_2_16_47_1 article-title: Setup errors in the applications of two immbolization techniques in neck irradiation publication-title: J Cancer Control Treat – ident: e_1_2_16_138_1 doi: 10.1158/1078-0432.CCR-17-2656 – ident: e_1_2_16_58_1 doi: 10.1118/1.4876299 – ident: e_1_2_16_84_1 doi: 10.1186/s12885-015-1669-z – ident: e_1_2_16_132_1 doi: 10.1093/annonc/mdu507 – ident: e_1_2_16_146_1 doi: 10.1016/j.currproblcancer.2020.100620 – ident: e_1_2_16_64_1 doi: 10.1002/mp.14075 – ident: e_1_2_16_29_1 doi: 10.1002/cncr.32770 – ident: e_1_2_16_5_1 doi: 10.1016/S0140-6736(19)30956-0 – ident: e_1_2_16_135_1 doi: 10.1016/j.ijrobp.2006.03.054 – ident: e_1_2_16_125_1 doi: 10.1186/s13014-019-1387-9 – ident: e_1_2_16_186_1 doi: 10.1200/JCO.2017.75.5165 – ident: e_1_2_16_8_1 doi: 10.1007/978-3-319-40618-3 – ident: e_1_2_16_35_1 doi: 10.1371/journal.pone.0219611 – ident: e_1_2_16_67_1 doi: 10.1118/1.3514120 – ident: e_1_2_16_70_1 doi: 10.1016/S0167-8140(00)00192-4 – ident: e_1_2_16_94_1 doi: 10.1016/j.radonc.2013.10.035 – ident: e_1_2_16_103_1 doi: 10.1093/jnci/djr432 – ident: e_1_2_16_205_1 doi: 10.1186/s40880-017-0256-x – ident: e_1_2_16_111_1 doi: 10.1016/j.ejca.2019.07.007 – ident: e_1_2_16_167_1 doi: 10.1200/JCO.2017.77.0388 – ident: e_1_2_16_164_1 doi: 10.1002/cncr.20802 – ident: e_1_2_16_199_1 doi: 10.1097/RMR.0b013e3181572b3a – ident: e_1_2_16_15_1 doi: 10.1186/s40880-017-0265-9 – ident: e_1_2_16_105_1 doi: 10.1093/jnci/dji084 – ident: e_1_2_16_165_1 doi: 10.1016/S1470-2045(18)30495-9 – ident: e_1_2_16_185_1 doi: 10.1002/lary.27317 – ident: e_1_2_16_93_1 doi: 10.1016/j.ijrobp.2019.06.2540 – ident: e_1_2_16_178_1 doi: 10.1016/j.ejca.2015.05.014 – ident: e_1_2_16_72_1 doi: 10.1016/j.ijrobp.2010.07.017 – ident: e_1_2_16_98_1 doi: 10.1016/j.radonc.2015.05.012 – ident: e_1_2_16_124_1 doi: 10.1016/j.oraloncology.2016.11.008 – ident: e_1_2_16_200_1 doi: 10.1586/era.10.9 – ident: e_1_2_16_97_1 doi: 10.1016/j.oraloncology.2018.04.025 – ident: e_1_2_16_176_1 doi: 10.1016/j.ctrv.2019.101890 – ident: e_1_2_16_122_1 doi: 10.1002/ijc.30819 – ident: e_1_2_16_86_1 doi: 10.1002/hed.23314 – ident: e_1_2_16_182_1 doi: 10.1002/hed.21928 |
| SSID | ssj0001989453 |
| Score | 2.6091003 |
| Snippet | Nasopharyngeal carcinoma (NPC) is a malignant epithelial tumor originating in the nasopharynx and has a high incidence in Southeast Asia and North Africa. To... Abstract Nasopharyngeal carcinoma (NPC) is a malignant epithelial tumor originating in the nasopharynx and has a high incidence in Southeast Asia and North... |
| SourceID | doaj pubmedcentral proquest pubmed crossref wiley |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1195 |
| SubjectTerms | Abdomen Accuracy Antigens Apoptosis Biopsy Cancer therapies Chemotherapy China Chinese Society of Clinical Oncology Clinical practice guidelines CSCO Diagnosis Epstein-Barr virus Guidelines and Consensus Humans Immunotherapy Lymphatic system Magnetic resonance imaging Medical diagnosis Medical Oncology Metastasis Nasopharyngeal carcinoma Nasopharyngeal Carcinoma - diagnosis Nasopharyngeal Carcinoma - therapy Nasopharyngeal Neoplasms - diagnosis Nasopharyngeal Neoplasms - therapy Oncology Radiation therapy Radiotherapy Risk Staging Surgery Throat cancer Tomography Tumors Ultrasonic imaging |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQT1wQiFegICM4UKTQxHYc51giqooDPUCl3qLxq1Qq3qrbPfTUv94ZJxvtigou3JJ4kjieceabZPwNYx-E00YZX5URnX2phLIltM6XFt0DNC7qyudsi-_66ER9O21ON0p9UU7YSA88Dty-r630sVXeS6OaEKAVuIuoGMDiTLb09kWftxFM5a8rxCveyJmPVOw7cOJzLQRV99jwQJmo_z50-WeS5CZ4zd7n8DF7NMFGfjB29wl7ENJTdos65lQAOywDn9Iv-SLyievzgh-nzEl9wz_2P_rjPb5eBsnPVsRuRSdyBK0cQSD3Y87d-ZJD8nzOP6frJaBaB3B1k84QVnJH5YfS4jc8YyeHX3_2R-VUUKF0tKS0lN55aKAzygVtZWU735nQtbU1vjE6oqs3unPR1xqPa28jyGBsSxGrFV2Uz9lOWqTwkvFQOaigUwBaq9qhkpooQnC2kiZ4Gwq2tx7kwU1s41T04mIYeZLFQAoZskIK9n6WvRw5Nu6V-kK6miWIFzsfQGsZJmsZ_mUtBdtda3qYJutywJAO40ZEQqJg7-ZmnGb07wRSWKxQpjFUCMB0VcFejIYx90QqjVGjqQvWbpnMVle3W9L5r0zlTfEk3r1gn7Jx_eXxh_6gF3nr1f8YiNfsoaDsnLyqcpftXF-twhuEV9f2bZ5Jd2qhJgk priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9QwELWgXLggEF-BglyVA0UKTWzHcU6oRK0qDvQAlfYW-StLpdYpu91DT_x1Zhxv2lWr3hLHSeyM7Xl2xu8R8olZqYRyRd6Ds88FEybXtXW5AfegK9vLwsVoi5_y-FT8mFWztOC2TGGV6zExDtRusLhGvg-4G8A9uCv27fJvjqpR-Hc1SWg8Jk-QugxDuupZfbPGguziFZ9YSdm-1ZZ9LRlDjY9bfijS9d-HMe-GSt6GsNEHHT0nzxJ4pAejtV-QRz68JP_A0hRlsP3S0xSESYeeJsbPc3oSIjP1Nf3c_mpP9uh6MySdr5DjCm-kAF0pQEHqxsi7syXVwdEpCh2fFzQqHujFdZgDuKQWRYjCcKFfkdOjw9_tcZ5kFXKLG0tz7qzTlW6UsF4aXpjGNco3dWmUq5TsweEr2djelRLSpTO95l6ZGuethjU9f022whD8W0J9YXWhG6G1lKK0peFVz7y3puDKO-Mzsrf-yJ1NnOMofXHejWzJrEODdNEgGdmd8l6OTBv35vqOtppyIDt2TBgW8y51ts5BQVxfC-e4EpX3umZwCjMprQ2M_iYj22tLd6nLLrubBpaRnekydDb8g6KDH1aQp1IoB6CaIiNvxoYxlYQLCXNHVWak3mgyG0XdvBLO_kRCb5xVwtsz8iU2rgeq37UHLYtH7x6uw3vylGH0Tdw1uU22rhYr_wHg05X5GPvIfyDzHDQ priority: 102 providerName: ProQuest |
| Title | The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcac2.12218 https://www.ncbi.nlm.nih.gov/pubmed/34699681 https://www.proquest.com/docview/2602872012 https://www.proquest.com/docview/2587004890 https://pubmed.ncbi.nlm.nih.gov/PMC8626602 https://doaj.org/article/d1b3df74dd3845eea72df7182aab876b |
| Volume | 41 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9NAEB6V9sIFgXgZSrQIDhTJ1F6v12uJS2tSVRyaCijKzdqXQ6Vio6Y5cOKvM7N2HCIqJC5RbI-TtWfH88165huA19xKJZRL4gadfSy4MLEurIsNuged20YmLmRbnMnTC_Fxns934P26FqbnhxgX3MgywvOaDFyb5eGGNNRqy9-lHF3UHdij2lpizufifLPCQtzigYaSY7QVZ4jNR35Sfrg5fcsjBeL-29Dm30mTf4LZ4I1O7sO9AUayo17vD2DHtw_hF-qcUUNsv_RsSMdkXcMG7s8rNmsDR_VP9qb6XM0O2Loski1WxHZFJzIEsQxBIXN9Dt7lkunWsTEfnX6v1dT7AO9cu0CYySy1I2q77_oRXJxMv1Sn8dBgIbZUYhpnzjqd61IJ66XJElO6UvmySI1yuZINun4lS9u4VOJ-6UyjM69MQRGs4WWTPYbdtmv9U2A-sTrRpdBaSpHa1GR5w723JsmUd8ZHcLC-ybUd2MepCcZV3fMm85oUUgeFRPBqlP3Rc27cKnVMuholiCc77OiuF_VgdrXDgbimEM5lSuTe64LjJsZUWhv0AyaC_bWm68F4lzWGeBhHIjLiEbwcD6PZ0bsU3fpuhTK5osYAqkwieNJPjHEkmZAYRao0gmJrymwNdftIe_ktUHtTfIn_HsHbMLn-cfl1dVTx8O3Z_wg_h7ucsnJCNeU-7N5cr_wLhFU3ZhKsBz-LeTGBvePp2fmnSViiwK3Z1-n0w2-4gCOA |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6V7QEuCMQrUMAIkChSaOI4jnNAqF1atbRsEbRSb8GvLJVKUna7QnviH_EbGTuPdkXVW2_ZxMk6mbHnm2T8fQCvqOaCCROFJQb7kFGmQplpEyoMDzLVJY-Mr7YY8e1D9ukoPVqCv91aGFdW2c2JfqI2tXbvyNcQdyO4x3BFP5z-Cp1qlPu62kloNG6xa-e_MWWbvt_5iPZ9TenW5sFwO2xVBULt1lWGidFGpjIXTFuukkjlJhc2z2IlTCp4ifFO8FyXJua4nxtVysQKlbm0TdG8TPC6N2CZJZjKDGB5Y3P05ev5Wx3HZ54mPQ8qXdNS03cxpU5V5ELk8wIBl6Ha_4szL4JmH_W27sDtFq6S9ca_7sKSre7BH_Qt4oS37dSStuyT1CVpOUZPyH7lubDn5M3w23B_lXTLL8l45li13IkEwTJB8ElMU-t3PCWyMqSve3fXq6TTWJCTeTVGOEu0kz2q6p_yPhxeyyN_AIOqruwjIDbSMpI5k5JzFutYJWlJrdUqSoQ1ygaw2j3kQrcs505s46Ro-Jlp4QxSeIME8LJve9pwe1zaasPZqm_h-Lj9jnoyLtrhXRjsiCkzZkwiWGqtzCj-xNxNSoXxRgWw0lm6aCeJaXHu0gG86A_j8HbfbGRl6xm2SYUTIBB5FMDDxjH6niSMY7Yq4gCyBZdZ6Oriker4h6cQd3ks_nsAb71zXXH7xXB9SP3W46vv4Tnc3D74vFfs7Yx2n8At6mp__JrNFRicTWb2KYK3M_WsHTEEvl_3IP0HPu9a2Q |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB6VVkJcEIhXoIARHChSaOIkjiNxWQKr8lCLBIsqLpafS6XiVN3ugRN_nbGTzbKiQuKWx8RxPJ7MN8n4G4BnVDNecpOlDp19WtJSpbLWJlXoHmSlHctMzLY4ZAez8v1xdbwFr1ZrYXp-iPGDW7CM-L4OBn5m3P6aNFRLTV_mFF3UFdgJNHk4p3cmX2ffZutvLIFdPBJRUoy30gLR-chQSvfXDWz4pEjdfxne_Dtt8k84G_3R9AZcH4AkmfSavwlb1t-CX6h1Ekpi24UlQ0Im6RwZ2D9PyZGPLNU_yfP2c3u0R1YLI8l8GfiuwoUEYSxBWEhMn4V3siDSGzJmpIf2vAzVD3Ds_ByBJtGhIJHvfsjbMJu-_dIepEOJhVSHRaZpYbSRlWx4qS1TRaYa03Db1LnipuLMofPnrNHO5AyPM6OcLCxXdYhhFW1ccQe2feftPSA20zKTTSklY2Wuc1VUjlqrVVZwa5RNYG81yEIP_OOhDMap6JmTqQgKEVEhCTwdZc961o1LpV4HXY0SgSk7HujO52IwPGGwI8bVpTEFLytrZU1xF6MqKRV6ApXA7krTYjDfhcAgDyNJxEY0gSfjaTS88DdFetstUabioTQAb7IE7vYTY-xJUTKMI3meQL0xZTa6unnGn3yP5N4hwsS7J_AiTq5_PL5oJy2NW_f_R_gxXP30Zio-vjv88ACu0ZCiE5dW7sL2xfnSPkSMdaEeDab0GymKItg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Chinese+Society+of+Clinical+Oncology+%28CSCO%29+clinical+guidelines+for+the+diagnosis+and+treatment+of+nasopharyngeal+carcinoma&rft.jtitle=Cancer+communications+%28London%2C+England%29&rft.au=Tang%2C+Ling%E2%80%90Long&rft.au=Chen%2C+Yu%E2%80%90Pei&rft.au=Chen%2C+Chuan%E2%80%90Ben&rft.au=Chen%2C+Ming%E2%80%90Yuan&rft.date=2021-11-01&rft.issn=2523-3548&rft.eissn=2523-3548&rft.volume=41&rft.issue=11&rft.spage=1195&rft.epage=1227&rft_id=info:doi/10.1002%2Fcac2.12218&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_cac2_12218 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2523-3548&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2523-3548&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2523-3548&client=summon |